IP/QB,10_NNP No_NNP ._.
4_CD ._.
(_( NEW_JJ SERIES_NNP ._.
SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ._.
ON_IN THE_DT ACTION_NNP OF_IN THE_NNP VENOMS_NNP OF_IN THE_NNP COBRA_NNP (_( NAJA_NNP TRIPUDIANS_NNP )_) AND_NNP OF_IN THE_NNP DABOIA_NNP (_( DABOIA_NNP RUSSELLII_NNP )_) ON_IN THE_NNP RED_NNP BLOOD_NNP CORPUSCLES_NNP AND_NNP ON_NNP THE_NNP BLOOD_NNP PLASMA_NNP ._.
BY_NNP GEORGE_NNP LAMB_NNP ,_, M.D._NNP ,_, CAPTAIN_NNP ,_, I.M.S_NNP ._.
ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75023878.tif_CD ]_JJ CALCUTTA_NNP :_: OFFICE_NN OF_IN THE_NNP SUPERINTENDENT_NNP OF_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP ._.
1903_CD ._.
Price_NN As_IN ._.
8_CD or_CC 9d_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75023884.tif_CD ]_JJ No_NNP ._.
4_CD ._.
(_( NEW_JJ SERIES_NNP ._. )_)
SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ._.
ON_IN THE_DT ACTION_NNP OF_IN THE_NNP VENOMS_NNP OF_IN THE_NNP COBRA_NNP (_( NAJA_NNP TRIPUDIANS_NNP )_) AND_NNP OF_IN THE_NNP DABOIA_NNP (_( DABOIA_NNP RUSSELLII_NNP )_) ON_IN THE_NNP RED_NNP BLOOD_NNP CORPUSCLES_NNP AND_NNP ON_NNP THE_NNP BLOOD_NNP PLASMA_NNP ._.
BY_NNP GEORGE_NNP LAMB_NNP ,_, M.D._NNP ,_, CAPTAIN_NNP ,_, I.M.S_NNP ._.
ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75023890.tif_CD ]_JJ [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75023890.tif_CD ]_JJ CALCUTTA_NNP :_: OFFICE_NN OF_IN THE_NNP SUPERINTENDENT_NNP OF_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP ._.
1903_CD ._.
Agents_NNS for_IN the_DT Sale_NNP of_IN Books_NNP published_VBN by_IN The_DT Superintendent_NNP of_IN Government_NNP Printing_NNP ,_, India_NNP ,_, Calcutta_NNP ._.
IN_NNP ENGLAND_NNP ._.
E._NNP A._NN ARNOLD_NNP ,_, 37_CD ,_, Bedford_NNP Street_NNP ,_, Strand_NNP ,_, London_NNP ,_, W.C._NNP CONSTABLE_NNP &_CC CO._NNP ,_, 2_CD ,_, Whitehall_NNP Gardens_NNP ,_, London_NNP ,_, S.W_NNP ._.
SAMPSON_NNP Low_NNP ,_, MARSTON_NNP &_CC CO._NNP ,_, St._NNP Dunstan_NNP 's_POS House_NNP ,_, Fetter_NNP Lane_NNP ,_, London_NNP ,_, E.C_NNP ._.
P._NNP S._NNP KING_NNP &_CC SON_NNP ,_, 2_CD &_CC 4_CD ,_, Great_NNP Smith_NNP Street_NNP ,_, Westminster_NNP ,_, London_NNP ,_, S.W_NNP ._.
LUZAC_NNP &_CC CO._NNP ,_, 46_CD ,_, Great_NNP Russell_NNP Street_NNP ,_, London_NNP ,_, W_NNP ._.
C._NNP KEGAN_NNP PAUL_NNP ,_, TRENCH_NNP ,_, TRUBNER_NNP &_CC CO._NNP ,_, Charing_NNP Cross_NNP Road_NNP ,_, London_NNP ,_, W.C._NNP B_NNP ._.
A._NN QUARITCH_NNP ,_, 15_CD ,_, Piccadilly_NNP ,_, London_NNP ,_, W._NNP WILLIAMS_NNP and_CC NORGATE_NNP ,_, Oxford_NNP ._.
DEIGHTON_NNP BELL_NNP &_CC CO._NNP ,_, Cambridge_NNP ._.
ON_IN THE_DT CONTINENT_NNP ._.
R._NNP FRIEDLON_NNP THE_NNP ACTION_NNP OF_IN THE_NNP VENOMS_NNP OF_IN THE_NNP COBRA_NNP (_( NAJA_NNP TRIPUDIANS_NNP )_) AND_NNP OF_IN THE_NNP DABOIA_NNP (_( DABOIA_NNP RUSSELLII_NNP )_) ON_IN THE_NNP RED_NNP BLOOD_NNP CORPUSCLES_NNP AND_NNP ON_NNP THE_NNP BLOOD_NNP PLASMA_NNP ._.
THE_DT action_NN of_IN the_DT different_JJ varieties_NNS of_IN snake_NN venom_NN on_IN the_DT constituents_NNS of_IN the_DT bood_NN and_CC on_IN the_DT blood_NN coagulability_NN is_VBZ a_DT subject_NN which_WDT has_VBZ engaged_VBN the_DT attention_NN of_IN various_JJ observers_NNS in_IN America_NNP ,_, Australia_NNP ,_, and_CC India_NNP ._.
A_DT study_NN of_IN the_DT literature_NN of_IN the_DT subject_NN '_POS makes_VBZ it_PRP evident_JJ that_IN all_DT venoms_NNS which_WDT have_VBP been_VBN worked_VBN with_IN have_VBP a_DT marked_VBN action_NN on_IN the_DT blood_NN ,_, the_DT effect_NN of_IN which_WDT is_VBZ mani-_JJ fested_VBN in_IN the_DT production_NN of_IN changes_NNS of_IN a_DT destructive_JJ nature_NN on_IN the_DT red_JJ corpus-_JJ cles_NNS ,_, as_RB well_RB as_IN in_IN an_DT alteration_NN of_IN the_DT coagulability_NN of_IN the_DT plasma_NN ._.
From_IN such_PDT a_DT study_NN ,_, however_RB ,_, it_PRP is_VBZ apparent_JJ that_IN no_DT investigator_NN has_VBZ attempted_VBN to_TO note_VB care-_JJ fully_RB the_DT differences_NNS which_WDT exist_VBP between_IN the_DT various_JJ poisons_NNS in_IN these_DT respects_NNS ._.
So_RB much_JJ so_RB is_VBZ this_DT the_DT case_NN ,_, that_IN Calmette_NNP of_IN Lille_NNP 2holds_CD the_DT opinion_NN that_IN all_DT snake_VBP venoms_NNS have_VBP exactly_RB the_DT same_JJ physiological_JJ actions_NNS and_CC only_RB differ_NN from_IN one_CD another_DT in_IN the_DT degree_NN of_IN toxicity_NN which_WDT they_PRP possess_VBP ,_, one_CD being_VBG more_JJR toxic_NN than_IN another_DT ._.
And_CC ,_, again_RB ,_, Martin_NNP of_IN Melbourne_NNP 3has_CD put_VBD forward_RB the_DT working_VBG hypothesis_NN ,_, founded_VBN on_IN his_PRP$ own_JJ experiments_NNS with_IN the_DT venoms_NNS of_IN the_DT Australian_JJ snakes_NNS ,_, Hoplocephalus_NNP and_CC Pseudechis_NNP ,_, and_CC on_IN the_DT researches_NNS of_IN others_NNS with_IN various_JJ venoms_NNS ,_, that_IN all_DT snake_VBP venoms_NNS contain_VBP two_CD or_CC more_JJR poisonous_JJ proteids_NNS ,_, and_CC that_IN in_IN the_DT varying_JJ proportions_NNS of_IN these_DT in_IN venoms_NNS from_IN different_JJ species_NNS of_IN snakes_NNS may_MD be_VB found_VBN the_DT explanation_NN of_IN the_DT different_JJ effects_NNS which_WDT follow_VBP the_DT inoculation_NN of_IN the_DT several_JJ poisons_NNS ._.
He_PRP thought_VBD that_IN the_DT proteids_NNS coagulable_JJ by_IN heat_NN acted_VBN on_IN the_DT blood_NN and_CC heart_NN ,_, while_IN the_DT incoagulable_JJ proteids_NNS acted_VBD on_IN the_DT central_JJ nervous_JJ system_NN ._.
Along_IN with_IN Dr._NNP Hanna_NNP 4I_CD have_VBP shown_VBN that_IN Calmette_NNP 's_POS statement_NN is_VBZ without_IN foundation_NN and_CC also_RB that_DT Martin_NNP 's_POS theory_NN does_VBZ not_RB ,_, in_IN all_DT probability_NN ,_, apply_VB to_TO the_DT two_CD venoms_NNS with_IN which_WDT I_PRP propose_VBP to_TO deal_VB in_IN this_DT paper_NN ._.
Further_RB ,_, the_DT facts_NNS which_WDT I_PRP have_VBP now_RB to_TO record_VB support_NN my_PRP$ previous_JJ observations_NNS and_CC show_VB without_IN a_DT doubt_NN that_IN in_IN their_PRP$ physiological_JJ actions_NNS ,_, the_DT effects_NNS of_IN which_WDT are_VBP seen_VBN in_IN the_DT changes_NNS in_IN the_DT blood_NN constituents_NNS and_CC plasma_NN ,_, the_DT venoms_NNS of_IN the_DT cobra_NN and_CC of_IN the_DT daboia_NN differ_VBP markedly_RB from_IN one_CD another_DT ,_, and_CC that_IN Calmette_NNP 's_POS statement_NN and_CC Martin_NNP 's_POS hypothesis_NN can_MD no_RB longer_RB pass_VB unchallenged_JJ and_CC must_MD be_VB consid-_JJ erably_RB modified_VBN to_TO fit_VB the_DT facts_NNS now_RB available_JJ ._.
In_IN the_DT present_JJ communication_NN ,_, then_RB ,_, I_PRP propose_VBP to_TO deal_VB (_( I_PRP )_) with_IN the_DT action_NN which_WDT the_DT venom_NN of_IN the_DT cobra_NN (_( Naja_NNP tripudians_NNS )_) and_CC the_DT venom_NN of_IN the_DT chain_NN viper_NN (_( Daboia_NNP Russellii_NNP )_) exert_NN on_IN the_DT red_JJ blood_NN corpuscles_NNS both_DT in_IN vivo_NN and_CC in_IN vitro_NN ,_, the_DT result_NN of_IN which_WDT action_NN is_VBZ manifested_VBN by_IN h√¶molysis_NN :_: and_CC (_( 2_CD )_) with_IN the_DT action_NN which_WDT these_DT two_CD poisons_NNS A2_VBP 2_CD have_VBP ,_, also_RB in_IN vivo_NN and_CC in_IN vitro_NN ,_, on_IN the_DT blood_NN plasma_NN ,_, as_IN seen_VBN in_IN an_DT altera-_JJ tion_NN of_IN its_PRP$ coagulability_NN ._.
At_IN the_DT outset_NN it_PRP would_MD be_VB well_RB to_TO give_VB a_DT short_JJ account_NN of_IN the_DT methods_NNS which_WDT were_VBD employed_VBN to_TO collect_VB and_CC to_TO conserve_VB the_DT poisons_NNS used_VBN in_IN the_DT experi-_JJ ments_NNS recorded_VBN below_IN ,_, so_RB as_IN to_TO ensure_VB that_IN the_DT results_NNS obtained_VBN were_VBD uniform_JJ and_CC comparable_JJ amongst_NN themselves_PRP ._.
The_DT venom_NN in_IN both_DT instances_NNS was_VBD collected_VBN over_IN a_DT period_NN of_IN some_DT months_NNS from_IN a_DT number_NN of_IN healthy_JJ living_NN snakes_NNS by_IN 'milking_VBG '_'' ,_, or_CC rather_RB squeezing_NN ,_, the_DT poison_NN glands_NNS ,_, the_DT secretion_NN being_VBG caught_VBN in_IN a_DT watch-glass_JJ held_NN in_IN a_DT pair_NN of_IN long_JJ forceps_NNS ._.
The_DT liquid_NN poison_NN was_VBD then_RB thoroughly_RB and_CC rapidly_RB dried_VBD over_IN calcium_NN chloride_NN ._.
The_DT stock_NN of_IN venom_NN ,_, got_VBD in_IN this_DT way_NN ,_, was_VBD kept_VBN in_IN an_DT air-tight_JJ tube_NN away_RB from_IN the_DT light_NN ._.
It_PRP has_VBZ been_VBN shown_VBN by_IN many_JJ investigators_NNS that_WDT snake_VBP venoms_NNS ,_, stored_VBD dry_JJ in_IN this_DT manner_NN ,_, preserve_VB their_PRP$ toxicity_NN unimpaired_VBN for_IN an_DT in-_JJ definite_JJ period_NN ._.
Before_IN being_VBG weighed_VBD the_DT venom_NN was_VBD pounded_VBN to_TO a_DT very_RB fine_JJ powder_NN and_CC was_VBD then_RB kept_VBN in_IN a_DT weighing_JJ bottle_NN over_IN sulphuric_JJ acid_NN or_CC calcium_NN chloride_NN ._.
This_DT precaution_NN is_VBZ necessary_JJ in_IN a_DT climate_NN in_IN which_WDT the_DT atmosphere_NN is_VBZ saturated_VBN with_IN moisture_NN such_JJ as_IN is_VBZ the_DT case_NN in_IN Bombay_NNP ._.
As_IN they_PRP were_VBD re-_JJ quired_JJ ,_, solutions_NNS of_IN definite_JJ strengths_NNS made_VBN with_IN saline_JJ solution_NN of_IN varying_VBG strength_NN ,_, as_IN indicated_VBN in_IN the_DT protocols_NNS ,_, were_VBD prepared_VBN ._.
No_DT solution_NN was_VBD kept_RB longer_JJR than_IN an_DT hour_NN or_CC two_CD before_IN being_VBG used_VBN ._.
As_IN the_DT supply_NN of_IN venom_NN was_VBD always_RB abundant_JJ ,_, fresh_JJ solutions_NNS were_VBD prepared_JJ every_DT day_NN upon_IN which_WDT experi-_JJ ments_NNS were_VBD made_VBN ._.
In_IN this_DT way_NN any_DT diminution_NN of_IN toxicity_NN ,_, which_WDT ,_, there_EX is_VBZ no_DT doubt_NN ,_, takes_VBZ place_NN when_WRB snake_NN venoms_NNS are_VBP kept_VBN in_IN solution_NN for_IN any_DT length_NN of_IN time_NN ,_, was_VBD avoided_VBN ._.
With_IN this_DT introduction_NN we_PRP may_MD now_RB pass_VB on_IN to_TO consider3_VB punctures_NNS a_DT marked_JJ infiltration_NN into_IN the_DT areolar_JJ tissues_NNS of_IN a_DT purple_JJ blood-like_JJ fluid_NN ,_, and_CC that_IN this_DT infiltration_NN contains_VBZ few_JJ red_JJ blood_NN corpuscles_NNS ._.
In_IN experimental_JJ observations_NNS on_IN animals_NNS ,_, especially_RB on_IN horses_NNS and_CC donkeys_NNS ,_, the_DT abscess_NN which_WDT sometimes_RB forms_NNS ,_, when_WRB a_DT sub-lethal_JJ dose_NN of_IN cobra_NN venom_NN is_VBZ given_VBN ,_, contains_VBZ thin_JJ red-coloured_JJ pus_NN ._.
Further_RB ,_, the_DT mucous_JJ discharges_NNS are_VBP sometimes_RB stained_VBN red_JJ ._.
Thus_RB ,_, I_PRP have_VBP seen_VBN a_DT marked_JJ red-stained_JJ discharge_NN from_IN the_DT rectum_NN of_IN an_DT ass_NN which_WDT had_VBD received_VBN a_DT little_RB over_IN the_DT minimum_JJ lethal_JJ dose_NN of_IN cobra_NN venom_NN ._.
As_IN I_PRP have_VBP said_VBD ,_, however_RB ,_, in_IN animal_JJ experiments_NNS with_IN cobra_NNS poison_VBP all_DT observers_NNS are_VBP agreed_VBN that_IN repeated_VBD microscopic_JJ examinations_NNS of_IN the_DT blood_NN of_IN animals_NNS ,_, which_WDT die_VBP from_IN cobra_NN venom_NN intoxication_NN ,_, show_VBP an_DT entire_JJ absence_NN of_IN any_DT appreciable_JJ structural_JJ change_NN in_IN the_DT red_JJ blood_NN cells_NNS ._.
The_DT probable_JJ explanation_NN of_IN this_DT fact_NN is_VBZ ,_, either_RB that_IN ,_, when_WRB a_DT large_JJ dose_NN has_VBZ been_VBN injected_VBN ,_, death_NN takes_VBZ place_NN so_RB rapidly_RB that_IN such_PDT a_DT marked_JJ destruction_NN of_IN the_DT cells_NNS has_VBZ not_RB had_VBN time_NN to_TO take_VB place_NN as_IN to_TO be_VB demonstrable_JJ by_IN microscopic_NN examination_NN ,_, or_CC that_IN ,_, when_WRB a_DT smaller_JJR dose_NN has_VBZ been_VBN given_VBN and_CC death_NN is_VBZ delayed_VBN ,_, the_DT quantity_NN of_IN venom_NN injected_VBN is_VBZ not_RB large_JJ enough_RB to_TO cause_VB any_DT extensive_JJ destruction_NN of_IN the_DT red_JJ cells_NNS ._.
While_IN this_DT fact_NN is_VBZ undoubted_JJ ,_, Cunningham_NNP 8has_CD shown_VBN in_IN several_JJ experi-_JJ ments_NNS that_IN ,_, if_IN the_DT blood_NN of_IN an_DT animal_NN which_WDT has_VBZ received_VBN a_DT large_JJ dose_NN of_IN cobra_NN venom_NN ,_, either_CC intravenously_RB or_CC subcutaneously_RB ,_, be_VB withdrawn_VBN from_IN the_DT body_NN after_IN death_NN and_CC allowed_VBN to_TO clot_VB ,_, the_DT serum_NN which_WDT exudes_VBZ from_IN the_DT clot_NN is_VBZ of_IN a_DT red_JJ colour_NN ;_: also_RB that_IN ,_, if_IN a_DT fowl_NN has_VBZ been_VBN the_DT animal_JJ employed_NN ,_, many_JJ free_JJ nuclei_NN of_IN the_DT red_JJ cells_NNS are_VBP found_VBN on_IN examining_VBG the_DT blood_NN at_IN death_NN ;_: there_EX has_VBZ been_VBN ,_, in_IN fact_NN ,_, a_DT considerable_JJ solution_NN of_IN the_DT bodies_NNS of_IN the_DT red_JJ cells_NNS ._.
Further_RB ,_, this_DT observer_NN has_VBZ demonstrated_VBN that_IN ,_, if_IN the_DT dose_NN of_IN venom_NN injected_VBN into_IN a_DT fowl_NN is_VBZ a_DT very_RB large_JJ one_CD ,_, namely_RB ,_, 100_CD to_TO 300_CD milligrammes_NNS ,_, the_DT blood_NN at_IN death_NN contains_VBZ a_DT great_JJ abundance_NN of_IN free_JJ nuclei_NN ,_, and_CC the_DT remaining_VBG red_JJ cells_NNS appear_VBP deformed_VBN ;_: he_PRP has_VBZ also_RB shown_VBN that_IN ,_, if_IN the_DT specimen_NNS be_VB allowed_VBN to_TO stand_VB ,_, at_IN the_DT end_NN of_IN a_DT few_JJ hours_NNS complete_JJ destruction_NN of_IN the_DT red_JJ cells_NNS will_MD have_VB taken_VBN place_NN ._.
I_PRP have_VBP been_VBN able_JJ to_TO confirm_VB these_DT statements_NNS of_IN Cunningham_NNP ._.
These_DT observations_NNS ,_, therefore_RB ,_, conclusively_RB show_VBP that_IN cobra_NN venom_NN does_VBZ have_VB a_DT certain_JJ amount_NN of_IN h√¶molytic_JJ action_NN in_IN vivo_NN ,_, even_RB when_WRB it_PRP is_VBZ injected_VBN in_IN moderate_JJ doses_NNS ._.
When_WRB ,_, however_RB ,_, a_DT quantity_NN of_IN venom_NN ,_, which_WDT will_MD bring_VB about_IN this_DT effect_NN in_IN a_DT marked_JJ degree_NN ,_, is_VBZ injected_VBN into_IN an_DT animal_NN ,_, the_DT animal_JJ dies_NNS so_RB rapidly_RB that_IN there_EX has_VBZ been_VBN time_NN for_IN complete_JJ destruction_NN of_IN only_RB a_DT comparatively_RB few_JJ cells_NNS to_TO take_VB place_NN ._.
It_PRP would_MD appear_VB ,_, therefore_RB ,_, from_IN √¢_JJ prior√Æ_NN reasons_NNS ,_, that_IN the_DT h√¶molysis_NN which_WDT results_NNS from_IN this_DT action_NN of_IN cobra_NN venom_NN can_MD have_VB little_JJ or_CC no_DT connection_NN with_IN the_DT nervous_JJ symptoms_NNS which_WDT are_VBP always_RB observed_VBN in_IN cases_NNS of_IN intoxication_NN with_IN this_DT poison_NN ,_, and_CC can_MD not_RB be_VB a_DT factor_NN in_IN producing_VBG the_DT fatal_JJ result_NN ._.
An_DT oppo-_JJ site_NN opinion_NN is_VBZ ,_, however_RB ,_, strongly_RB held_VBN by_IN Cunningham_NNP ._.
4_CD The_DT destructive_JJ action_NN of_IN cobra_NN venom_NN on_IN the_DT red_JJ blood_NN cells_NNS in_IN vitro_NN has_VBZ been_VBN investigated_VBN by_IN several_JJ observers_NNS ._.
Thus_RB ,_, Cunningham,9_NNP by_IN drawing_VBG blood_NN directly_RB into_IN solutions_NNS of_IN cobra_NN venom_NN ,_, found_VBD that_IN the_DT serum_NN which_WDT exuded_VBD from_IN any_DT clot_NN which_WDT formed_VBD was_VBD dark_JJ red_JJ or_CC brownish_JJ in_IN colour_NN ._.
He_PRP demon-_RB strated_VBD this_DT phenomenon_NN both_DT with_IN mammalian_JJ bloods_NNS and_CC with_IN fowl_NN 's_POS blood_NN ._.
Kanthack,10_NNP Stephens,11_NNP and_CC Myers_NNP 12_CD have_VBP also_RB demonstrated_VBN the_DT marked_JJ h√¶mo-_JJ lytic_JJ action_NN of_IN cobra_NN venom_NN in_IN vitro_NN ._.
These_DT observers_NNS further_RBR noticed_VBD that_IN the_DT blood_NN cells_NNS of_IN different_JJ animals_NNS were_VBD of_IN different_JJ susceptibility_NN to_TO this_DT h√¶molysing_VBG poison_NN ,_, and_CC that_IN this_DT susceptibility_NN of_IN the_DT blood_NN cells_NNS bore_VBD no_DT relation_NN to_TO the_DT general_JJ susceptibility_NN of_IN the_DT animals_NNS to_TO subcutaneous_JJ injection_NN of_IN the_DT poison_NN ._.
The_DT most_RBS convenient_JJ and_CC most_JJS reliable_JJ method_NN to_TO demonstrate_VB and_CC to_TO estimate_VB this_DT h√¶molytic_JJ action_NN in_IN vitro_NN ,_, the_DT method_NN which_WDT I_PRP have_VBP employed_VBN in_IN all_DT my_PRP$ experiments_NNS ,_, is_VBZ stated_VBN as_IN follows_VBZ ._.
The_DT venom_NN is_VBZ dissolved_VBN in_IN a_DT solution_NN of_IN common_JJ salt_NN ,_, isotonic_JJ 13_CD for_IN the_DT parti-_JJ cular_JJ blood_NN under_IN observation_NN ._.
This_DT solution_NN of_IN venom_NN is_VBZ made_VBN of_IN a_DT strength_NN of_IN 1_CD c.c..=2_NN milligrammes_NNS ,_, namely_RB ,_, 0.2_CD per_IN cent_NN ._.
From_IN this_DT original_JJ solution_NN a_DT suc-_JJ cession_NN of_IN two_CD fold_JJ dilutions_NNS ,_, made_VBN with_IN salt_JJ solution_NN of_IN the_DT same_JJ strength_NN as_IN the_DT original_JJ solution_NN of_IN venom_NN ,_, is_VBZ prepared_VBN in_IN a_DT series_NN of_IN test_NN tubes_NNS ,_, so_IN that_IN each_DT dilution_NN contains_VBZ half_PDT the_DT amount_NN of_IN poison_NN of_IN the_DT one_NN just_RB above_IN it_PRP in_IN the_DT series_NN ._.
A_DT conve-_JJ nient_NN quantity_NN ,_, namely_RB ,_, 0_CD 5_CD c.c._NN ,_, of_IN each_DT dilution_NN is_VBZ then_RB measured_VBN into_IN a_DT series_NN of_IN small_JJ test_NN tubes_NNS ._.
To_TO each_DT tube_NN a_DT measured_JJ quantity_NN of_IN fresh_JJ blood_NN is_VBZ added_VBN by_IN means_NNS of_IN a_DT graduated_JJ capillary_JJ pipette_NN ._.
The_DT quantity_NN of_IN blood_NN I_PRP found_VBD most_RBS suit-_JJ able_JJ to_TO add_VB to_TO each_DT tube_NN was_VBD 0.005_CD c.c_NN ._.
In_IN these_DT operations_NNS care_NN must_MD be_VB taken_VBN to_TO avoid_VB ,_, as_RB far_RB as_IN possible_JJ ,_, any_DT bacterial_JJ contamination_NN ._.
Ordinary_JJ precautions_NNS ,_, however_RB ,_, of_IN having_VBG sterile_JJ tubes_NNS ,_, sterile_JJ salt_NN solution_NN and_CC sterile_JJ pipettes_NNS are_VBP all_PDT that_DT are_VBP requisite_JJ ._.
Control_NNP tubes_NN of_IN salt_JJ solution_NN and_CC blood_NN alone_RB are_VBP prepared_VBN in_IN all_DT experiments_NNS ._.
The_DT mixtures_NNS are_VBP allowed_VBN to_TO stand_VB at_IN laboratory_JJ temperature_NN (_( about_IN 25¬∞_CD C._NNP )_) for_IN 20_CD to_TO 24_CD hours_NNS ._.
It_PRP is_VBZ then_RB observed_VBN in_IN which_WDT tubes_VBP complete_JJ laking_NN has_VBZ taken_VBN place_NN ,_, in_IN which_WDT partial_JJ laking_NN and_CC in_IN which_WDT no_DT laking_NN at_IN all_DT ._.
When_WRB there_EX is_VBZ any_DT doubt_NN from_IN the_DT naked_JJ eye_NN appearances_NNS as_IN to_TO whether_IN complete_JJ or_CC only_RB partial_JJ h√¶molysis_NN has_VBZ taken_VBN place_NN ,_, a_DT microscopic_NN examination_NN will_MD soon_RB settle_VB the_DT point_NN ._.
Working_VBG in_IN this_DT way_NN ,_, I_PRP have_VBP been_VBN able_JJ to_TO confirm_VB the_DT general_JJ results_NNS got_VBD by_IN the_DT observers_NNS mentioned_VBN above_IN ;_: and_CC ,_, further_RB ,_, to_TO estimate_VB fairly_RB accurately_RB the_DT h√¶molysing_VBG power_NN of_IN cobra_NN venom_NN towards_IN the_DT blood_NN of_IN several_JJ varieties_NNS of_IN animals_NNS ._.
But_CC ,_, inasmuch_RB as_IN the_DT results_NNS obtained_VBD lead_JJ to_TO the_DT same_JJ conclusions_NNS as_IN were_VBD arrived_VBN at_IN by_IN the_DT observers_NNS mentioned_VBN above_IN ,_, it_PRP is_VBZ unneces-_JJ sary_JJ to_TO detail_VB these_DT experiments_NNS ._.
It_PRP is_VBZ ,_, however_RB ,_, well_UH to_TO point_VB out_RP that_IN slight_JJ variations_NNS occur_VBP ,_, from_IN time_NN to_TO time_NN ,_, in_IN the_DT minimum_JJ amount_NN of_IN venom_NN which_WDT will_MD produce_VB h√¶molysis_NN of_IN the_DT blood_NN of_IN any_DT particular_JJ species_NNS of_IN animal_NN ._.
Such_JJ variations_NNS were_VBD also_RB noticed_VBN by_IN Kanthack_NNP ,_, but_CC they_PRP are_VBP never_RB so_RB marked_JJ as_IN to_TO 5_CD invalidate_NN the_DT general_JJ results_NNS ._.
They_PRP are_VBP ,_, in_IN fact_NN ,_, quite_RB explicable_JJ on_IN the_DT ground_NN of_IN experimental_JJ error_NN ._.
In_IN view_NN of_IN Martin_NNP 's_POS hypothesis_NN ,_, mentioned_VBN on_IN page_NN I_PRP ,_, it_PRP is_VBZ important_JJ to_TO be_VB able_JJ to_TO put_VB on_IN record_NN some_DT experiments_NNS which_WDT bear_VBP on_IN the_DT effect_NN which_WDT heating_VBG solutions_NNS of_IN cobra_NN venom_NN has_VBZ on_IN the_DT h√¶molytic_JJ action_NN of_IN this_DT poison_NN ._.
In_IN Table_NNP I_PRP of_IN the_DT protocols_NNS are_VBP shown_VBN the_DT results_NNS of_IN such_JJ experiments_NNS ._.
From_IN this_DT Table_NN it_PRP will_MD be_VB seen_VBN that_IN ,_, while_IN heating_VBG solutions_NNS of_IN cobra_NN venom_NNS so_RB as_IN to_TO precipitate_VB all_PDT the_DT coagulable_JJ proteids_NNS does_VBZ not_RB destroy_VB the_DT h√¶molysing_VBG power_NN of_IN the_DT venom_NN ,_, such_JJ heating_NN does_VBZ cause_VB a_DT diminution_NN of_IN this_DT power_NN ,_, and_CC that_IN this_DT diminution_NN is_VBZ more_RBR marked_JJ if_IN the_DT solution_NN which_WDT is_VBZ heated_VBN be_VB a_DT comparatively_RB weak_JJ solution_NN ._.
Thus_RB ,_, two_CD solutions_NNS of_IN cobra_NN venom_NN were_VBD made_VBN of_IN 1_CD per_IN cent_NN ._.
and_CC 0.1_CD per_IN cent_NN ._.
strength_NN respectively_RB ._.
These_DT were_VBD heated_VBN in_IN the_DT same_JJ water_NN bath_NN for_IN half_PDT an_DT hour_NN at_IN 73¬∞_CD C._NNP The_DT coagulated_JJ proteids_NNS were_VBD then_RB filtered_VBN off_RP ._.
The_DT h√¶molysing_VBG power_NN of_IN the_DT same_JJ sample_NN of_IN venom_NN ,_, unheated_JJ ,_, and_CC of_IN these_DT two_CD heated_VBD solutions_NNS ,_, was_VBD estimated_VBN after_IN the_DT method_NN I_PRP have_VBP described_VBN above_IN ._.
A_DT reference_NN to_TO the_DT protocols_NNS will_MD show_VB that_IN the_DT greatest_JJS dilution_NN of_IN venom_NN ,_, in_IN which_WDT complete_NN or_CC almost_RB complete_JJ h√¶moloysis_NN was_VBD obtained_VBN in_IN each_DT instance_NN ,_, was_VBD as_IN follows:6_JJ bowel_NN ,_, from_IN the_DT mouth,7_NN hours_NNS a_DT firm_NN clot_NN had_VBD formed_VBN ,_, and_CC the_DT serum_NN which_WDT had_VBD exuded_VBN was_VBD of_IN the_DT same_JJ colour_NN as_IN the_DT whole_JJ plasma_NN got_VBD by_IN centrifugalisation_NN ._.
The_DT urine_NN collected_VBN from_IN the_DT bladder_NN was_VBD dark_VBN in_IN colour_NN like_IN porter_NN ._.
It_PRP contained_VBD exceedingly_RB few_JJ red_JJ blood_NN corpuscles_NNS ,_, only_RB two_CD or_CC three_CD being_VBG visible_JJ in_IN a_DT microscopic_JJ field_NN ._.
I_PRP have_VBP been_VBN able_JJ to_TO produce_VB similar_JJ symptoms_NNS and_CC evidence_NN of_IN marked_JJ h√¶molysis_NN by_IN injections_NNS of_IN this_DT venom_NN into_IN monkeys_NNS ,_, rabbits_NNS ,_, and_CC pigeons_NNS ._.
These_DT observations_NNS ,_, therefore_RB ,_, show_VBP positively_RB that_IN daboia_NN venom_NN has_VBZ a_DT very_RB marked_JJ and_CC intense_JJ destructive_JJ action_NN in_IN vivo_NN on_IN the_DT red_JJ blood_NN corpuscles_NNS of_IN most_JJS animals_NNS ,_, and_CC that_IN the_DT effects_NNS of_IN this_DT action_NN are_VBP important_JJ factors_NNS in_IN the_DT production_NN of_IN the_DT symptoms_NNS observed_VBD and_CC of_IN the_DT fatal_JJ result_NN ._.
To_TO anyone_NN who_WP has_VBZ worked_VBN with_IN both_DT cobra_NNS and_CC daboia_NN venoms_NNS the_DT marked_VBN difference_NN which_WDT exists_VBZ between_IN their_PRP$ h√¶molytic_JJ actions_NNS in_IN vivo_NN must_MD be_VB apparent_JJ ._.
The_DT h√¶mo-_JJ lysis_NN produced_VBN by_IN cobra_NN venom_NN might_MD easily_RB escape_VB observation_NN ,_, while_IN in_IN the_DT case_NN of_IN daboia_NN poison_NN it_PRP is_VBZ a_DT most_RBS prominent_JJ feature_NN of_IN the_DT intoxication_NN ._.
Such_JJ being_VBG the_DT case_NN ,_, one_CD would_MD expect_VB to_TO find_VB that_IN a_DT marked_JJ h√¶molytic_JJ action_NN with_IN daboia_JJ venom_NN would_MD be_VB easy_JJ to_TO demonstrate_VB in_IN vitro_NN ,_, similar_JJ to_TO the_DT h√¶molytic_JJ action_NN which_WDT I_PRP have_VBP mentioned_VBN is_VBZ easily_RB got_VBN in_IN vitro_NN with_IN cobra_JJ venom_NN ._.
This_DT surmise_NN ,_, however_RB ,_, does_VBZ not_RB hold_VB good_JJ ._.
Thus_RB Stephens,17_NNP as_IN a_DT result_NN of_IN a_DT few_JJ experiments_NNS only_RB ,_, has_VBZ come_VBN to_TO the_DT conclusion_NN that_IN ,_, while_IN daboia_JJ venom_NNS dissolved_VBN in_IN saline_JJ solution_NN has_VBZ no_DT h√¶molysing_VBG power_NN in_IN vitro_NN on_IN the_DT red_JJ cells_NNS of_IN men_NNS ,_, this_DT poison_NN has_VBZ a_DT marked_VBN destructive_JJ power_NN on_IN the_DT human_JJ red_JJ corpuscles_NNS if_IN it_PRP is_VBZ dissolved_VBN in_IN normal_JJ horse_NN serum_NN ._.
On_IN the_DT other_JJ hand_NN ,_, Cunningham_NNP 18_CD found_VBD that_IN ,_, if_IN the_DT blood_NN of_IN a_DT fowl_NN is_VBZ run_VBN into_IN solutions_NNS of_IN daboia_NN venom_NN ,_, the_DT serum_NN which_WDT exudes_VBZ from_IN the_DT clot_NN ,_, which_WDT ,_, he_PRP remarks_NNS ,_, is_VBZ always_RB soft_JJ and_CC tremulous_JJ ,_, is_VBZ dark_JJ and_CC red_JJ in_IN colour_NN ,_, showing_VBG that_IN a_DT considerable_JJ destruction_NN of_IN the_DT red_JJ cells_NNS has_VBZ taken_VBN place_NN ._.
Using_VBG a_DT similar_JJ technique_NN to_TO that_DT which_WDT I_PRP have_VBP described_VBN above_IN in_IN the_DT experiments_NNS with_IN cobra_NN venom_NN ,_, I_PRP have_VBP found_VBN that_IN it_PRP is_VBZ possible_JJ to_TO demonstrate_VB that_IN daboia_NN venom_NN dissolved_VBN in_IN saline_JJ solution_NN does_VBZ produce_VB in_IN vitro_JJ laking_NN of_IN the_DT blood_NN of_IN many_JJ animals_NNS ._.
This_DT action_NN ,_, how-_JJ ever_RB ,_, is_VBZ somewhat_RB variable_JJ ._.
Care_NN has_VBZ to_TO be_VB taken_VBN that_IN the_DT salt_NN solution_NN is_VBZ not_RB of_IN too_RB great_JJ a_DT strength_NN ;_: that_DT ,_, in_IN fact_NN ,_, it_PRP is_VBZ just_RB slightly_RB stronger_JJR than_IN the_DT solution_NN which_WDT would_MD of_IN itself_PRP produce_VBP a_DT certain_JJ amount_NN of_IN laking_NN ._.
In_IN Table_NNP II_NNP of_IN the_DT protocols_NNS the_DT results_NNS of_IN five_CD series_NN of_IN experiments_NNS of_IN this_DT description_NN are_VBP detailed_VBN ._.
The_DT bloods_NNS used_VBN were_VBD those_DT of_IN man_NN ,_, monkey_NN ,_, rabbit_NN ,_, guinea-pig_NN ,_, and_CC pigeon_VB re-_JJ spectively_RB ._.
The_DT strength_NN of_IN the_DT salt_JJ solution_NN employed_VBN for_IN each_DT variety_NN of_IN blood_NN was_VBD previously_RB determined_VBN by_IN actual_JJ experiment_NN ._.
This_DT strength_NN is_VBZ in_IN each_DT instance_NN indicated_VBN in_IN the_DT protocols_NNS ._.
A_DT glance_NN at_IN this_DT table_NN will_MD show_VB that_IN ,_, while_IN the_DT control_NN tube_NN in_IN every_DT in-_JJ stance_NN showed_VBD no_DT h√¶molysis_NN ,_, a_DT marked_VBN and_CC even_RB complete_JJ laking_VBG took_VBD place_NN B_NNP 8_CD in_IN many_JJ of_IN the_DT venom_NN tubes_NNS ._.
It_PRP will_MD also_RB be_VB seen_VBN that_IN the_DT action_NN is_VBZ somewhat_RB variable_JJ ,_, that_WDT is_VBZ to_TO say_VB ,_, the_DT h√¶molysis_NN obtained_VBN in_IN a_DT tube_NN containing_VBG a_DT weak_JJ solution_NN of_IN venom_NN is_VBZ sometimes_RB more_RBR complete_JJ than_IN in_IN tubes_JJ containing_NN stronger_JJR solutions_NNS ._.
Thus_RB ,_, it_PRP has_VBZ often_RB been_VBN observed_VBN in_IN one_CD series_NN of_IN tubes_NNS that_WDT while_IN the_DT stronger_JJR solutions_NNS of_IN venom_NN have_VBP only_RB a_DT slight_NN or_CC no_DT destructive_JJ action_NN on_IN the_DT red_JJ cells_NNS ,_, the_DT result_NN of_IN the_DT action_NN of_IN the_DT weaker_JJR solutions_NNS is_VBZ an_DT absolutely_RB complete_JJ h√¶molysis_NN ._.
Such_JJ a_DT result_NN is_VBZ well_RB shown_VBN in_IN the_DT series_NN of_IN experiments_NNS with_IN the_DT blood_NN of_IN a_DT rabbit_NN tabulated_VBN in_IN Table_NNP III_NNP of_IN the_DT protocols_NNS ._.
This_DT variability_NN in_IN the_DT h√¶molytic_JJ action_NN of_IN daboia_NN venom_NN in_IN vitro_NN is_VBZ in_IN marked_JJ contrast_NN to_TO the_DT results_NNS obtained_VBD with_IN cobra_JJ venom_NN ._.
This_DT ,_, however_RB ,_, is_VBZ a_DT point_NN to_TO which_WDT I_PRP shall_MD return_VB ._.
When_WRB a_DT weak_JJ solution_NN (_( viz._NN ,_, 0.1_CD per_IN cent_NN ._. )_)
of_IN daboia_NN venom_NN is_VBZ heated_VBN so_RB as_IN to_TO coagulate_VB the_DT coagulable_JJ proteids_NNS ,_, the_DT h√¶molytic_JJ property_NN ,_, which_WDT the_DT unheated_JJ venom_NN has_VBZ in_IN vitro_NN ,_, is_VBZ completely_RB destroyed_VBN ._.
In_IN Table_NNP IV_NNP of_IN the_DT protocols_NNS two_CD parallel_JJ series_NN of_IN experiments_NNS are_VBP detailed_VBN in_IN order_NN to_TO demonstrate_VB this_DT face_NN ._.
In_IN these_DT observations_NNS a_DT 0.1_CD per_IN cent_NN ._.
solution_NN of_IN venom_NN in_IN 0.6_CD per_IN cent_NN ._.
saline_JJ solution_NN was_VBD divided_VBN into_IN two_CD portions_NNS ._.
One_CD por-_JJ tion_NN was_VBD left_VBN unheated_JJ ,_, while_IN the_DT other_JJ portion_NN was_VBD heated_VBN in_IN a_DT water_NN bath_NN for_IN half_PDT an_DT hour_NN at_IN 75¬∞_CD C._NNP The_DT coagulated_JJ proteids_NNS were_VBD then_RB filtered_VBN off_RP ._.
The_DT h√¶moly-_JJ sing_VBG power_NN of_IN each_DT portion_NN ,_, heated_VBN and_CC unheated_JJ ,_, was_VBD then_RB determined_VBN in_IN the_DT manner_NN I_PRP have_VBP already_RB described_VBN ,_, the_DT blood_NN of_IN the_DT same_JJ rabbit_NN being_VBG used_VBN in_IN each_DT instance_NN ._.
It_PRP will_MD be_VB seen_VBN from_IN this_DT table_NN that_IN ,_, while_IN the_DT unheated_JJ solution_NN showed_VBD a_DT well_NN marked_VBN h√¶molytic_JJ action_NN in_IN many_JJ of_IN the_DT tubes_NNS ,_, no_DT laking_NN was_VBD observed_VBN in_IN any_DT of_IN the_DT tubes_NNS containing_VBG the_DT dilutions_NNS of_IN the_DT heated_JJ venom_NN ._.
We_PRP may_MD pause_VB here_RB for_IN a_DT moment_NN to_TO sift_VB the_DT data_NNS contained_VBN in_IN the_DT obser-_JJ vations_NNS and_CC experiments_NNS which_WDT I_PRP have_VBP put_VBN forward_RB above_IN ,_, with_IN the_DT view_NN of_IN sum-_JJ marising_VBG the_DT differences_NNS which_WDT exist_VBP between_IN the_DT h√¶molysing_VBG action_NN of_IN cobra_NN venom_NN and_CC that_IN of_IN daboia_NN venom_NN ._.
Firstly_RB ,_, as_IN regards_NNS the_DT h√¶molysis_NN which_WDT these_DT venoms_NNS produce_VBP in_IN vivo_NN ,_, it_PRP is_VBZ important_JJ to_TO note_VB that_IN cobra_NN venom_NN ,_, howsoever_NN introduced_VBD into_IN the_DT body_NN ,_, exerts_VBZ only_RB a_DT slight_JJ destructive_JJ action_NN on_IN the_DT red_JJ cells_NNS ,_, so_IN that_RB ,_, as_IN a_DT rule_NN ,_, no_DT symptoms_NNS result_NN ._.
Indeed_RB the_DT results_NNS of_IN this_DT particular_JJ action_NN of_IN the_DT poison_NN have_VBP generally_RB escaped_VBN observation_NN ._.
On_IN the_DT other_JJ hand_NN ,_, the_DT h√¶molytic_JJ action_NN of_IN daboia_NN venom_NN in_IN vivo_NN is_VBZ well_RB marked_VBN and_CC leads_VBZ to_TO a_DT train_NN of_IN symptoms_NNS ,_, which_WDT are_VBP very_RB prominent_JJ to_TO even_RB a_DT casual_JJ observer_NN ._.
Secondly_RB ,_, when_WRB the_DT h√¶molysing_VBG power_NN of_IN these_DT two_CD poisons_NNS is_VBZ estimated_VBN side_NN by_IN side_NN in_IN vitro_NN ,_, using_VBG exactly_RB the_DT same_JJ technique_NN in_IN each_DT case_NN ,_, we_PRP have_VBP seen_VBN that_IN ,_, while_IN this_DT action_NN of_IN cobra_NN venom_NN is_VBZ well_RB marked_VBN and_CC regular_JJ ,_, varying_VBG according_VBG to_TO the_DT strength_NN of_IN the_DT venom_JJ solution_NN used_VBN ,_, no_DT matter_NN from_IN what_WP species_NNS of_IN animal_NN the_DT blood_NN is_VBZ taken_VBN ,_, the_DT destructive_JJ effect_NN on_IN the_DT red_JJ cells_NNS 9_CD of_IN daboia_NN venom_NN ,_, under_IN similar_JJ circumstances_NNS ,_, varies_NNS considerably_RB and_CC often_RB apparently_RB does_VBZ not_RB depend_VB on_IN the_DT strength_NN of_IN the_DT poison_NN solution_NN with_IN which_WDT the_DT blood_NN is_VBZ brought_VBN in_IN contact_NN ._.
This_DT action_NN of_IN daboia_NN venom_NN in_IN vitro_NN is_VBZ ,_, in_IN fact_NN ,_, by_IN no_DT means_NNS so_RB definite_RB as_IN the_DT corresponding_JJ action_NN of_IN cobra_NN venom_NN ._.
Thirdly_RB ,_, we_PRP have_VBP seen_VBN that_IN heating_VBG a_DT 0.1_CD per_IN cent_NN ._.
solution_NN of_IN cobra_NN venom_NN ,_, while_IN diminishing_VBG ,_, does_VBZ not_RB completely_RB destroy_VB ,_, the_DT h√¶molysing_VBG property_NN of_IN the_DT poison_NN ;_: and_CC that_IN heating_VBG a_DT solution_NN of_IN daboia_JJ venom_NN of_IN the_DT same_JJ strength_NN and_CC in_IN exactly_RB the_DT same_JJ manner_NN has_VBZ the_DT effect_NN of_IN completely_RB destroying_VBG the_DT h√¶moly-_JJ tic_JJ power_NN which_WDT the_DT unheated_JJ solution_NN possessed_VBD ._.
It_PRP seems_VBZ ,_, therefore_RB ,_, justifiable_JJ to_TO conclude_VB from_IN these_DT three_CD facts_NNS that_RB ,_, as_RB far_RB as_IN the_DT h√¶molysing_NN substances_NNS of_IN these_DT venoms_NNS are_VBP concerned_VBN ,_, we_PRP are_VBP dealing_VBG with_IN substances_NNS different_JJ but_CC resembling_VBG one_CD another_DT ,_, and_CC that_IN in_IN this_DT respect_NN ,_, as_IN in_IN all_DT other_JJ respects_NNS ,_, cobra_NN venom_NN and_CC daboia_NN venom_NN ,_, although_IN at_IN first_JJ sight_NN presenting_VBG a_DT superficial_JJ resemblance_NN ,_, yet_RB differ_VBP materially_RB from_IN one_CD another_DT ._.
The_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN ._.
It_PRP has_VBZ been_VBN known_VBN for_IN some_DT time_NN that_IN many_JJ snake_VBP venoms_NNS have_VBP a_DT well_NN marked_VBN action_NN on_IN the_DT coagulability_NN of_IN the_DT blood_NN plasma_NN in_IN vivo_NN ._.
To_TO this_DT fact_NN attention_NN was_VBD first_JJ drawn_VBN by_IN Fontana,19_NNP who_WP more_RBR than_IN a_DT hundred_CD years_NNS ago_RB noticed_VBD that_IN the_DT blood_NN remained_VBD fluid_NN in_IN animals_NNS dead_JJ of_IN viper-bite_JJ ._.
Brainard_NNP 19_CD and_CC ._.
Weir_NNP Mitchell_NNP 19have_CD also_RB shown_VBN that_IN rattle-snake_NN venom_NN has_VBZ a_DT marked_VBN ac-_JJ tion_NN on_IN the_DT coagulability_NN of_IN the_DT blood_NN ._.
The_DT former_JJ observer_NN noticed_VBD that_IN in_IN animals_NNS which_WDT died_VBD immediately_RB after_IN a_DT rattle-snake_JJ bite_NN ,_, the_DT blood_NN was_VBD clotted_VBN ;_: while_IN ,_, if_IN death_NN was_VBD delayed_VBN for_IN any_DT length_NN of_IN time_NN ,_, the_DT blood_NN remained_VBD fluid_NN in_IN the_DT vessels_NNS ._.
Weir_NNP Mitchell_NNP ,_, while_IN confirming_VBG those_DT observations_NNS ,_, explained_VBD the_DT differences_NNS by_IN the_DT hypothesis_NN that_IN in_IN cases_NNS of_IN very_RB rapid_JJ death_NN the_DT poison_NN had_VBD not_RB had_VBN time_NN to_TO affect_VB the_DT blood_NN ._.
In_IN Australia_NNP ,_, Halford_NNP 19observed_CD the_DT same_JJ fluidity_NN of_IN the_DT blood_NN to_TO follow_VB the_DT injection_NN of_IN the_DT venom_NN of_IN some_DT Australian_JJ snakes_NNS ._.
Further_RB ,_, the_DT continued_JJ fluidity_NN of_IN the_DT blood_NN after_IN death_NN from_IN the_DT bite_NN of_IN the_DT Indian_JJ viperine_NN snakes_NNS has_VBZ been_VBN frequently_RB noted_VBN by_IN numerous_JJ observers_NNS in_IN this_DT country_NN ._.
The_DT work_NN ,_, however_RB ,_, of_IN Martin_NNP of_IN Melbourne_NNP 20with_CD the_DT venoms_NNS of_IN the_DT two_CD Australian_JJ snakes_NNS (_( Hoplocephalus_NNP and_CC Pseudechis_NNP )_) put_VBD this_DT problem_NN on_IN a_DT firmer_JJR basis_NN ._.
This_DT careful_JJ observer_NN has_VBZ shown_VBN that_IN the_DT venoms_NNS of_IN these_DT two_CD species_NNS of_IN snakes_NNS produce_VBP ,_, when_WRB injected_VBN intravenously_RB in_IN sufficient_JJ amount_NN ,_, such_PDT a_DT marked_JJ increase_NN in_IN the_DT blood_NN coagulability_NN as_IN to_TO lead_VB to_TO an_DT extensive_JJ intravascular_JJ throm-_JJ bosis_NN ,_, but_CC that_IN ,_, if_IN the_DT quantity_NN injected_VBN is_VBZ not_RB sufficient_JJ to_TO cause_VB death_NN from_IN this_DT B_NNP 2_CD 10_CD thrombosis_NN ,_, then_RB a_DT marked_JJ deficiency_NN or_CC negative_JJ phase_NN of_IN the_DT blood_NN coagula-_JJ bility_NN follows_VBZ a_DT short-lived_JJ phase_NN of_IN increased_JJ coagulability_NN ._.
Here_RB ,_, then_RB ,_, was_VBD the_DT probable_JJ explanation_NN of_IN the_DT results_NNS obtained_VBN by_IN the_DT American_JJ investigators_NNS with_IN crotalus_JJ venom_NNS ._.
Martin_NNP ,_, further_RB ,_, put_VBD forward_RB the_DT hypothesis_NN that_IN all_DT snake_VBP venoms_NNS prob-_JJ ably_RB contained_VBN ,_, in_IN greater_JJR or_CC less_JJR quantity_NN ,_, the_DT same_JJ proteid_NN substance_NN which_WDT brought_VBD about_IN this_DT most_RBS remarkable_JJ effect_NN on_IN the_DT blood_NN coagulability_NN ,_, one_CD venom_NN differing_VBG from_IN another_DT in_IN the_DT amount_NN of_IN this_DT constituent_NN ._.
Along_IN with_IN Dr._NNP Hanna_NNP 21_CD I_PRP was_VBD ,_, however_RB ,_, able_JJ to_TO show_VB that_IN this_DT hypothesis_NN was_VBD not_RB a_DT sufficient_JJ explanation_NN as_RB far_RB as_IN our_PRP$ Indian_JJ snakes_NNS were_VBD concerned_VBN ._.
For_IN we_PRP proved_VBD beyond_IN a_DT doubt_NN that_IN ,_, while_IN the_DT effect_NN of_IN the_DT action_NN of_IN daboia_NN venom_NN on_IN the_DT blood_NN coagu-_JJ lability_NN was_VBD apparently_RB the_DT same_JJ as_IN Martin_NNP had_VBD described_VBN with_IN regard_NN to_TO the_DT venom_NN of_IN the_DT Australian_JJ species_NNS ,_, cobra_NN venom_NN did_VBD not_RB at_IN any_DT rate_NN ,_, even_RB when_WRB injected_VBN intravenously_RB in_IN very_RB large_JJ quantity_NN ,_, produce_VBP intravascular_JJ clotting_NN ._.
Again_RB ,_, in_IN a_DT paper_NN on_IN ``_`` Some_DT effects_NNS upon_IN the_DT blood_NN produced_VBN by_IN the_DT injection_NN of_IN the_DT venom_NN of_IN Pseudechis_NNP ,_, ''_'' Martin_NNP 22critically_CD sifts_VBD the_DT available_JJ data_NNS ,_, in_IN an_DT endeavour_NN to_TO find_VB an_DT explanation_NN of_IN the_DT significance_NN of_IN the_DT phenomena_NN which_WDT he_PRP described_VBD ._.
He_PRP arrives_VBZ at_IN the_DT conclusion_NN that_IN the_DT great_JJ changes_NNS which_WDT snake_VBP venoms_NNS bring_VBP about_IN on_IN the_DT blood_NN coagulability_NN are_VBP in_IN all_DT probability_NN due_JJ to_TO nucleo-proteids_JJ set_VBN free_JJ from_IN various_JJ cells_NNS ,_, especially_RB the_DT red_JJ blood_NN corpuscles_NNS ,_, as_IN a_DT result_NN of_IN their_PRP$ destruction_NN by_IN the_DT venom_NN ,_, and_CC he_PRP compares_VBZ the_DT phenomena_NN he_PRP observed_VBD in_IN using_VBG snake_JJ venom_NN with_IN the_DT phenomena_NN which_WDT Wooldridge_NNP described_VBD ,_, as_IN resulting_VBG from_IN an_DT injection_NN of_IN nucleo-proteids_NNS directly_RB into_IN the_DT blood_NN stream_NN of_IN an_DT animal_NN ._.
It_PRP is_VBZ unnecessary_JJ to_TO follow_VB this_DT observer_NN in_IN the_DT close_NN reasoning_VBG which_WDT runs_VBZ through_IN this_DT paper_NN ._.
It_PRP is_VBZ ,_, however_RB ,_, necessary_JJ to_TO point_VB out_RP that_IN at_IN the_DT close_NN of_IN the_DT paper_NN he_PRP sums_VBZ up_RP as_IN follows_VBZ :11_NN of_IN snake_NN poison_NN will_MD have_VB to_TO be_VB considered_VBN separately_RB ._.
I_PRP propose_VBP ,_, then_RB ,_, to_TO take_VB my_PRP$ considerations_NNS and_CC observations_NNS in_IN more_RBR or_CC less_RBR chronological_JJ order_NN ;_: firstly_RB ,_, stating_VBG briefly_NN the_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN the_DT coagulation_NN of_IN the_DT blood_NN as_IN observed_VBN in_IN vivo_NN ;_: and_CC secondly_RB ,_, passing_VBG on_IN to_TO consider_VB more_RBR in_IN detail_NN their_PRP$ effect_NN on_IN the_DT coagulability_NN of_IN the_DT whole_JJ blood_NN and_CC of_IN the_DT blood_NN plasma_NN in_IN vitro_NN ._.
Wall_NNP 23_CD states_NNS in_IN his_PRP$ work_NN on_IN Indian_JJ snake_NN venoms_NNS ,_, that_IN the_DT blood_NN in_IN the_DT human_JJ subject_NN at_IN post-mortem_JJ examination_NN of_IN cases_NNS of_IN cobra_NN venom_NN intoxication_NN is_VBZ ,_, as_IN a_DT rule_NN ,_, in_IN a_DT fluid_JJ condition_NN and_CC clots_NNS badly_RB on_IN being_VBG withdrawn_VBN from_IN the_DT vessels_NNS ._.
In_IN animal_JJ experiments_NNS ,_, however_RB ,_, this_DT observer_NN found_VBD that_IN the_DT blood_NN on_IN post-mortem_JJ examination_NN was_VBD always_RB clotted_VBN solidly_RB ._.
On_IN the_DT other_JJ hand_NN ,_, Cunningham_NNP 24_CD has_VBZ shown_VBN that_IN ,_, if_IN an_DT animal_NN received_VBD a_DT large_JJ quantity_NN of_IN cobra_NN venom_NN and_CC died_VBD very_RB shortly_RB after_IN the_DT injection_NN ,_, the_DT blood_NN drawn_NN just_RB before_RB or_CC immediately_RB after_IN death_NN remained_VBD unclotted_JJ for_IN a_DT considerable_JJ length_NN of_IN time_NN ,_, and_CC the_DT clot_NN which_WDT did_VBD ultimately_RB form_NN was_VBD semi-fluid_JJ ,_, loose_JJ and_CC soft_JJ ,_, and_CC no_DT serum_NN separated_VBD out_RP ._.
Neither_DT of_IN these_DT observers_NNS makes_VBZ any_DT record_NN of_IN finding_VBG immediately_RB after_IN death_NN any_DT intravascular_JJ thrombosis_NN ._.
This_DT condition_NN ,_, however_RB ,_, they_PRP might_MD easily_RB have_VB overlooked_VBN ,_, in_IN the_DT same_JJ way_NN as_IN they_PRP both_DT failed_VBD to_TO ob-_JJ serve_VB the_DT intravascular_NN clotting_VBG which_WDT results_NNS from_IN an_DT intravenous_JJ injection_NN of_IN daboia_NN venom_NN ._.
In_IN a_DT recent_JJ publication_NN along_IN with_IN Dr._NNP Hanna_NNP 25_CD I_PRP was_VBD able_JJ to_TO record_VB defin-_NN itely_RB the_DT fact_NN that_IN cobra_NN venom_NN ,_, even_RB when_WRB injected_VBN in_IN large_JJ quantity_NN into_IN a_DT vein_NN ,_, does_VBZ not_RB produce_VB any_DT intravascular_JJ clotting_NN ._.
An_DT amount_NN of_IN cobra_NN poison_NN ,_, as_RB great_JJ as_IN fifty_JJ times_NNS the_DT amount_NN of_IN daboia_NN venom_NN which_WDT can_MD cause_VB extensive_JJ intra-_JJ vascular_JJ thrombosis_NN ,_, was_VBD found_VBN to_TO have_VB no_DT such_JJ effect_NN ._.
It_PRP is_VBZ ,_, therefore_RB ,_, certain_JJ that_IN ,_, in_IN whatever_WDT other_JJ respects_NNS these_DT two_CD venoms_NNS may_MD differ_VB from_IN one_CD another_DT ,_, they_PRP do_VBP differ_VB in_IN this_DT particular_JJ physiological_JJ action_NN ,_, namely_RB ,_, cobra_JJ venom_NN does_VBZ not_RB produce_VB intravascular_JJ clotting_NN ;_: while_NN ,_, as_IN we_PRP shall_MD see_VB ,_, daboia_VB venom_JJ intro-_JJ duced_VBN intravenously_RB even_RB in_IN minute_NN doses_NNS does_VBZ possess_VB this_DT remarkable_JJ property_NN ._.
If_IN a_DT non-lethal_JJ dose_NN of_IN cobra_NN venom_NN is_VBZ injected_VBN subcutaneously_RB into_IN an_DT animal_NN ,_, one_CD seldom_NN sees_VBZ any_DT symptoms_NNS which_WDT might_MD point_VB ,_, as_IN is_VBZ the_DT case_NN with_IN daboia_NN venom_NN ,_, to_TO any_DT diminution_NN of_IN the_DT blood_NN coagulability_NN ._.
I_PRP have_VBP ,_, however_RB ,_, observed_VBN on_IN several_JJ occasions_NNS during_IN the_DT process_NN of_IN immunisation_NN of_IN horses_NNS and_CC donkeys_NNS which_WDT received_VBD an_DT injection_NN of_IN this_DT venom_NN over_IN the_DT shoulder_NN ,_, a_DT large_JJ 12_CD at_IN this_DT table_NN will_MD show_VB that_IN in_IN every_DT experiment_NN a_DT slight_JJ lengthening_NN of_IN the_DT normal_JJ coagulation_NN time_NN of_IN rabbit_NN 's_POS blood_NN followed_VBD the_DT venom_NN injection_NN ,_, and_CC that_IN this_DT diminution_NN in_IN coagulability_NN was_VBD more_RBR marked_JJ the_DT nearer_NN the_DT quantity_NN of_IN venom_NN injected_VBN approached_VBD to_TO the_DT minimum_JJ lethal_NN dose_NN ._.
These_DT experiments_NNS might_MD also_RB explain_VB Wall_NNP 's_POS failure_NN to_TO observe_VB any_DT post-mortem_JJ fluidity_NN of_IN the_DT blood_NN in_IN his_PRP$ animal_JJ experiments_NNS and_CC Cunningham_NNP 's_POS success_NN in_IN this_DT respect_NN ._.
For_IN it_PRP is_VBZ apparent_JJ that_IN ,_, if_IN a_DT dose_NN of_IN cobra_NN venom_NN which_WDT kills_VBZ in_IN from_IN 6_CD to_TO 10_CD hours_NNS be_VB given_VBN ,_, the_DT deficiency_NN in_IN coagulability_NN may_MD not_RB have_VB had_VBN time_NN to_TO develop_VB or_CC may_MD be_VB so_RB slight_JJ as_IN to_TO escape_VB observation_NN on_IN post-mortem_JJ examination_NN ,_, while_IN a_DT larger_JJR quantity_NN ,_, such_JJ as_IN Cunningham_NNP used_VBD ,_, and_CC which_WDT killed_VBD within_IN a_DT few_JJ minutes_NNS ,_, may_MD cause_VB a_DT marked_JJ deficiency_NN in_IN the_DT blood_NN coagulability_NN of_IN fairly_RB rapid_JJ onset_VBN by_IN reason_NN of_IN ``_`` mass_JJ action_NN ._. ''_''
To_TO sum_VB up_RP ,_, then_RB ,_, it_PRP is_VBZ certain_JJ that_IN cobra_NN venom_NN in_IN vivo_NN does_VBZ not_RB produce_VB any_DT increase_NN but_CC rather_RB a_DT deficiency_NN of_IN the_DT blood_NN coagulability_NN ,_, the_DT amount_NN of_IN this_DT deficiency_NN depending_VBG upon_IN the_DT quantity_NN of_IN venom_NN injected_VBN ,_, the_DT mode_NN of_IN its_PRP$ injection_NN and_CC the_DT time_NN allowed_VBN for_IN its_PRP$ action_NN to_TO take_VB place_NN ._.
Before_IN passing_VBG on_IN to_TO the_DT consideration_NN of_IN the_DT action_NN of_IN cobra_NN venom_NN on_IN the_DT whole_JJ blood_NN and_CC on_IN the_DT blood_NN plasma_NN in_IN vitro_NN ,_, it_PRP would_MD be_VB well_RB ,_, in_IN order_NN to_TO secure_VB a_DT consecutive_JJ story_NN ,_, to_TO draw_VB attention_NN briefly_NN to_TO some_DT observations_NNS which_WDT I_PRP have_VBP ,_, along_IN with_IN Dr._NNP Hanna_NNP ,_, already_RB published_VBN 25_CD on_IN the_DT action_NN of_IN daboia_NN venom_NN on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN ._.
Both_DT Wall_NNP 26_CD and_CC Cunningham_NNP 27_CD attributed_VBD the_DT rapid_JJ death_NN which_WDT follows_VBZ the_DT intravenous_JJ or_CC subcutaneous_JJ injection_NN of_IN daboia_NN venom_NN to_TO a_DT direct_JJ action_NN of_IN the_DT poison_NN on_IN the_DT central_JJ nervous_JJ system_NN ._.
They_PRP considered_VBD that_IN daboia_NN venom_NN in_IN all_DT instances_NNS caused_VBD a_DT fluidity_NN of_IN the_DT blood_NN ,_, sometimes_RB amounting_VBG to_TO complete_JJ loss_NN of_IN coagulability_NN ._.
Hanna_NNP and_CC I_PRP ,_, 28_CD however_RB ,_, were_VBD able_JJ to_TO show_VB that_IN this_DT hypothesis_NN was_VBD erroneous_JJ and_CC that_IN the_DT rapid_JJ death_NN which_WDT follows_VBZ an_DT injection_NN of_IN daboia_NN venom_NN is_VBZ invariably_RB caused_VBN by_IN extensive_JJ intravascular_JJ thrombosis_NN ._.
Further_RB ,_, we_PRP showed_VBD that_IN ,_, if_IN the_DT amount_NN of_IN venom_NN injected_VBN is_VBZ not_RB sufficient_JJ to_TO cause_VB this_DT thrombosis_NN ,_, a_DT negative_JJ phase_NN of_IN diminished_JJ coagulability_NN results_NNS ,_, sometimes_RB amounting_VBG to_TO complete_VB inhibition_NN of_IN clotting_NN ,_, and_CC that_IN this_DT diminished_JJ coagula-_JJ bility_NN is_VBZ probably_RB an_DT important_JJ factor_NN in_IN the_DT production_NN of_IN some_DT of_IN the_DT symptoms_NNS which_WDT are_VBP observed_VBN in_IN these_DT cases_NNS ._.
We_PRP found_VBD that_IN ,_, while_IN 0.1_CD milligramme_NNS of_IN daboia_NN venom_FW per_IN kilo_NN of_IN weight_NN when_WRB injected_VBN intravenously_RB into_IN a_DT rabbit_NN causes_VBZ extensive_JJ intravascular_JJ clotting_NN ,_, 0¬∑4_CD milligramme_NN has_VBZ the_DT same_JJ effect_NN when_WRB in-_NN jected_VBD subcutaneously_RB into_IN a_DT pigeon_NN ._.
This_DT thrombosis_NN may_MD be_VB confined_VBN ,_, if_IN the_DT quantity_NN of_IN venom_NN injected_VBN has_VBZ not_RB been_VBN excessive_JJ ,_, to_TO the_DT portal_NN veins_NNS ,_, the_DT right_JJ heart_NN and_CC the_DT pulmonary_JJ arteries_NNS :_: in_IN these_DT cases_NNS the_DT blood_NN collected_VBN from_IN the_DT other_JJ veins_NNS ,_, and_CC from_IN the_DT left_JJ heart_NN specially_RB ,_, remains_VBZ unclotted_JJ or_CC clots_NNS only_RB after_IN a_DT long_JJ interval_NN of_IN time_NN ,_, when_WRB the_DT clot_NN is_VBZ very_RB loose_JJ and_CC gelatinous_JJ ._.
We_PRP 13_CD also_RB showed_VBD that_IN ,_, when_WRB the_DT negative_JJ phase_NN of_IN diminished_JJ coagulability_NN had_VBD once_RB set_VBN in_IN ,_, it_PRP was_VBD impossible_JJ to_TO produce_VB increased_JJ coagulability_NN and_CC thrombosis_NN by_IN the_DT injection_NN of_IN any_DT quantity_NN of_IN venom_NN which_WDT under_IN normal_JJ circumstances_NNS injected_VBD intravenously_RB would_MD have_VB been_VBN ample_JJ to_TO bring_VB about_IN these_DT phenomena_NNS ._.
The_DT action_NN ,_, then_RB ,_, of_IN daboia_JJ venom_NN on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN is_VBZ very_RB definite_JJ and_CC well_RB marked_VBN ,_, and_CC corresponds_VBZ exactly_RB ,_, as_RB far_RB as_IN can_MD be_VB judged_VBN from_IN the_DT observation_NN of_IN the_DT symptoms_NNS and_CC the_DT results_NNS of_IN post-mortem_JJ examinations_NNS ,_, to_TO the_DT action_NN ,_, as_IN described_VBN by_IN Martin_NNP ,_, of_IN the_DT venoms_NNS of_IN the_DT two_CD Australian_JJ colubrine_NN snakes_NNS ,_, namely_RB ,_, Hoplocephalus_NNP and_CC Pseudechis_NNP ._.
Until_IN ,_, however_RB ,_, researches_NNS have_VBP been_VBN made_VBN with_IN the_DT specific_JJ sera_NN prepared_VBN with_IN these_DT poisons_NNS ,_, it_PRP would_MD be_VB premature_JJ even_RB to_TO suggest_VB that_IN daboia_JJ venom_NN was_VBD of_IN the_DT same_JJ nature_NN as_IN Hop-_NNP locephalus_NN and_CC Pseudechis_NNP venoms_NNS even_RB as_IN regards_NNS its_PRP$ blood_NN poison_NN ._.
The_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN the_DT coagulability_NN of_IN the_DT blood_NN in_IN vitro_NN ._.
We_PRP may_MD now_RB pass_VB on_IN to_TO consider_VB if_IN these_DT snake_VBP venoms_NNS have_VBP any_DT definite_JJ action_NN on_IN the_DT coagulation_NN of_IN the_DT blood_NN when_WRB mixed_JJ with_IN this_DT in_IN vitro_NN ,_, In_IN this_DT connection_NN I_PRP shall_MD have_VB to_TO put_VB on_IN record_NN some_DT experiments_NNS which_WDT I_PRP have_VBP made_VBN with_IN cobra_NN and_CC daboia_NN venoms_NNS with_IN the_DT whole_JJ blood_NN and_CC with_IN the_DT blood_NN plasma_NN freed_NN from_IN red_JJ cells_NNS ._.
With_IN the_DT poison_NN of_IN Pseudechis_NNP ,_, Martin_NNP 29_CD found_VBD that_IN by_IN running_VBG fresh_JJ blood_NN into_IN a_DT solution_NN (_( ¬∑01_JJ per_IN cent_NN ._. )_)
of_IN this_DT venom_NN ,_, clotting_VBG was_VBD considerably_RB delayed_VBN ,_, and_CC the_DT clot_NN which_WDT did_VBD form_NN was_VBD soft_JJ ,_, and_CC on_IN shrinking_VBG failed_VBN to_TO entangle_VB the_DT corpuscles_NNS ._.
Working_VBG with_IN crotalus_JJ poison_NN ,_, Weir_NNP Mitchell_NNP and_CC Reichert_NNP 30_CD were_VBD able_JJ to_TO prevent_VB coagulation_NN of_IN the_DT blood_NN altogether_RB in_IN vitro_NN ._.
These_DT observers_NNS drew_VBD the_DT blood_NN directly_RB into_IN a_DT vessel_NN containing_VBG a_DT strong_JJ solution_NN of_IN venom_JJ sur-_NN rounded_VBN by_IN a_DT freezing_JJ mixture_NN ._.
On_IN allowing_VBG the_DT temperature_NN to_TO rise_VB gradually_RB they_PRP found_VBD the_DT blood_NN remained_VBD permanently_RB liquid_JJ ._.
Further_RB ,_, both_DT Cunningham_NNP 31_CD and_CC Kanthack_NNP 32_CD have_VBP shown_VBN that_IN when_WRB fresh_JJ blood_NN was_VBD run_VBN into_IN a_DT strong_JJ solution_NN of_IN cobra_NN venom_NN ,_, either_CC it_PRP remained_VBD perma-_JJ nently_RB unclotted_JJ ,_, or_CC the_DT clot_NN which_WDT formed_VBD after_IN a_DT considerable_JJ delay_NN was_VBD soft_JJ and_CC gelatinous_JJ and_CC no_DT serum_NN exuded_VBD ._.
The_DT former_JJ of_IN these_DT observers_NNS also_RB states_VBZ that_IN in_IN three_CD experiments_NNS ,_, in_IN which_WDT blood_NN was_VBD run_VBN into_IN solutions_NNS of_IN daboia_NN venom_NN ,_, although_IN clotting_VBG took_VBD place_NN with_IN normal_JJ rapidity_NN ,_, the_DT clots_NNS which_WDT formed_VBD were_VBD loose_JJ ,_, soft_JJ ,_, and_CC tremulous_JJ ._.
These_DT observations_NNS ,_, therefore_RB ,_, would_MD tend_VB to_TO show_VB that_IN in_IN vitro_NN all_DT snake_VBP venoms_NNS have_VBP a_DT similar_JJ action_NN on_IN the_DT blood_NN coagulation_NN ,_, namely_RB ,_, an_DT inhibitory_JJ action_NN ._.
In_IN view_NN of_IN the_DT facts_NNS recorded_VBN above_IN as_IN regards_NNS the_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN ,_, it_PRP appeared_VBD to_TO me_PRP necessary_JJ 14_CD to_TO investigate_VB further_RBR this_DT action_NN in_IN vitro_NN of_IN these_DT two_CD venoms_NNS ,_, the_DT only_RB two_CD which_WDT were_VBD available_JJ to_TO me_PRP at_IN the_DT time_NN ._.
After_IN many_JJ failures_NNS to_TO get_VB any_DT definite_JJ results_NNS by_IN the_DT method_NN followed_VBN by_IN the_DT older_JJR investigators_NNS ,_, namely_RB ,_, the_DT method_NN of_IN allowing_VBG fresh_JJ blood_NN to_TO flow_VB directly_RB into_IN a_DT solution_NN of_IN venom_NN ,_, I_PRP was_VBD led_VBN to_TO use_VB blood_NN which_WDT was_VBD kept_VBN liquid_NN by_IN the_DT addition_NN of_IN citrate_NN of_IN soda_NN ._.
At_IN a_DT later_JJ date_NN I_PRP found_VBD that_IN similar_JJ results_NNS were_VBD obtained_VBN with_IN citrate_NN and_CC oxalate_NN plasma_NN ,_, which_WDT had_VBD been_VBN completely_RB freed_VBN from_IN the_DT red_JJ corpuscles_NNS by_IN allowing_VBG these_DT latter_JJR to_TO sediment_VB ,_, and_CC then_RB syphoning_VBG off_RP the_DT clear_JJ supernatant_JJ fluid_NN ._.
The_DT observations_NNS ,_, therefore_RB ,_, which_WDT I_PRP have_VBP now_RB to_TO record_VB naturally_RB fall_VB into_IN two_CD groups_NNS ,_, as_IN follows_VBZ :15_NNP blood_NN stream_NN ,_, produce_VBP intravascular_JJ clotting_NN ,_, it_PRP was_VBD not_RB to_TO be_VB expected_VBN that_IN this_DT poison_NN would_MD have_VB the_DT property_NN of_IN clotting_VBG citrate_NN blood_NN in_IN vitro_NN ._.
Such_JJ a_DT surmise_NN was_VBD found_VBN to_TO be_VB correct_JJ ._.
For_IN it_PRP will_MD be_VB seen_VBN on_IN reference_NN to_TO Table_NNP VI_NNP of_IN the_DT protocols_NNS that_WDT when_WRB 20_CD or_CC even_RB 30_CD milligrammes_NNS of_IN cobra_NN venom_NNS were_VBD added_VBN to_TO 1_CD c.c_NN ._.
of_IN citrate_NN blood_NN ,_, no_DT clot_NN formed_VBD after_IN 2_CD hours_NNS ,_, and_CC further_RB ,_, that_IN on_IN the_DT addition_NN ,_, after_IN this_DT interval_NN of_IN time_NN ,_, of_IN such_PDT an_DT amount_NN of_IN soluble_JJ lime_JJ salt_NN as_IN clotted_VBD the_DT control_NN in_IN 3_CD minutes_NNS ,_, the_DT blood_NN remained_VBD permanently_RB liquid_JJ ._.
As_IN we_PRP shall_MD see_VB later_RB ,_, this_DT is_VBZ a_DT very_RB different_JJ result_NN to_TO that_DT got_VBD in_IN similar_JJ experiments_NNS with_IN daboia_JJ venom_NN ._.
We_PRP can_MD say_VB ,_, then_RB ,_, that_IN a_DT large_JJ quantity_NN of_IN cobra_NN venom_NN does_VBZ not_RB increase_VB blood_NN coagulability_NN in_IN vitro_NN but_CC completely_RB prevents_NNS clotting_VBG taking_VBG place_NN ._.
We_PRP have_VBP also_RB seen_VBN above_IN that_DT cobra_NN venom_NN ,_, injected_VBN subcutaneously_RB or_CC in-_JJ travenously_RB even_RB in_IN small_JJ sub-lethal_JJ doses_NNS ,_, has_VBZ the_DT effect_NN of_IN diminishing_VBG the_DT coagulability_NN of_IN the_DT blood_NN ._.
By_IN means_NNS of_IN a_DT technique_NN such_JJ as_IN I_PRP have_VBP described_VBN above_IN ,_, the_DT optimum_JJ quantity_NN of_IN lime_JJ solution_NN necessary_JJ for_IN rapid_JJ clotting_NN of_IN the_DT control_NN being_VBG added_VBN to_TO each_DT tube_NN two_CD hours_NNS after_IN the_DT addition_NN of_IN the_DT cobra_NN venom_NN ,_, a_DT result_NN comparable_JJ to_TO what_WP obtains_VBZ in_IN vivo_NN can_MD be_VB got_VBN in_IN vitro_NN with_IN citrate_JJ whole_JJ blood_NN ._.
Thus_RB ,_, I_PRP was_VBD able_JJ to_TO estimate_VB fairly_RB accurately_RB ,_, as_IN judged_VBN from_IN a_DT number_NN of_IN experiments_NNS ,_, the_DT minimum_JJ quantity_NN of_IN cobra_NN venom_NN which_WDT can_MD keep_VB 1_CD c.c_NN ._.
of_IN citrate_JJ rabbit_NN blood_NN permanently_RB liquid_VBZ in_IN vitro_NN ,_, and_CC the_DT minimum_NN quantity_NN which_WDT distinctly_RB inhibits_VBZ ,_, but_CC does_VBZ not_RB altogether_RB prevent_NN ,_, coagulation_NN ._.
The_DT result_NN of_IN such_JJ an_DT estimation_NN is_VBZ detailed_VBN in_IN Table_NNP VII_NNP of_IN the_DT protocols_NNS ._.
From_IN this_DT table_NN it_PRP will_MD be_VB seen_VBN that_IN 0.4_CD milligramme_NN of_IN cobra_NN venom_NN kept_VBD 1_CD c.c_NN ._.
of_IN blood_NN liquid_NN for_IN at_IN least_JJS 20_CD hours_NNS ,_, and_CC that_IN 0¬∑01_CD milligramme_NNS had_VBD a_DT distinct_JJ inhibitory_JJ action_NN on_IN the_DT coagulability_NN of_IN the_DT same_JJ amount_NN of_IN blood_NN ,_, lengthening_VBG the_DT coagulation_NN time_NN ,_, as_IN compared_VBN with_IN the_DT control_NN ,_, by_IN about_IN half_PDT an_DT hour_NN ._.
It_PRP may_MD be_VB mentioned_VBN in_IN passing_VBG that_IN the_DT interval_NN of_IN time_NN allowed_VBN to_TO elapse_VB between_IN the_DT addition_NN of_IN the_DT venom_NN and_CC the_DT soluble_JJ lime_NN salt_NN in_IN some_DT cases_NNS affects_VBZ the_DT results_NNS of_IN experiments_NNS such_JJ as_IN I_PRP have_VBP collated_VBN above_IN ._.
Especially_RB is_VBZ this_DT the_DT case_NN when_WRB the_DT quantity_NN of_IN poison_NN used_VBN is_VBZ not_RB greatly_RB in_IN excess_NN of_IN the_DT mini-_JJ mum_NN amount_NN requisite_NN to_TO keep_VB the_DT blood_NN permanently_RB liquid_VBZ ._.
A_DT reference_NN to_TO Table_NNP VIII_NNP will_MD make_VB the_DT meaning_NN of_IN this_DT statement_NN clear_JJ ._.
It_PRP requires_VBZ no_DT further_JJ explanation_NN ,_, except_IN to_TO state_NN that_IN it_PRP was_VBD ,_, however_RB ,_, found_VBD in_IN many_JJ experiments_NNS that_WDT even_RB when_WRB the_DT cobra_NN venom_NN and_CC the_DT lime_JJ solution_NN were_VBD added_VBN together_RB ,_, the_DT same_JJ inhibition_NN of_IN coagulation_NN resulted_VBD ,_, as_IN when_WRB a_DT certain_JJ interval_NN of_IN time_NN was_VBD allowed_VBN to_TO elapse_VB ._.
Such_JJ a_DT result_NN as_IN I_PRP have_VBP tabulated_VBN in_IN Table_NNP VIII_NNP is_VBZ exceptional_JJ and_CC can_MD not_RB be_VB depended_VBN on_IN ._.
In_IN view_NN of_IN Martin_NNP 's_POS hypothesis_NN ,_, that_IN the_DT proteids_NNS coagulable_JJ by_IN heat_NN are_VBP the_DT constituents_NNS of_IN snake_NN venoms_NNS which_WDT affect_VBP the_DT blood_NN ,_, it_PRP is_VBZ important_JJ to_TO be_VB C_NNP 16_CD able_JJ to_TO record_VB an_DT observation_NN bearing_NN on_IN the_DT effect_NN which_WDT heating_VBG a_DT solution_NN of_IN cobra_NN venom_NN ,_, so_RB as_IN to_TO coagulate_VB the_DT coagulable_JJ proteids_NNS ,_, has_VBZ on_IN this_DT anti-clot-_JJ ting_VBG power_NN of_IN the_DT poison_NN ._.
Such_JJ experiments_NNS are_VBP detailed_VBN in_IN Table_NNP IX_NNP of_IN the_DT protocols_NNS ._.
Inasmuch_RB as_IN the_DT same_JJ technique_NN was_VBD used_VBN in_IN these_DT experiments_NNS as_IN was_VBD employed_VBN in_IN the_DT similar_JJ series_NN of_IN experiments_NNS with_IN unheated_JJ venom_NN detailed_VBN in_IN Table_NNP VII_NNP ,_, one_CD is_VBZ able_JJ to_TO compare_VB the_DT results_NNS recorded_VBD in_IN these_DT two_CD Tables_NNS ._.
From_IN such_PDT a_DT comparison_NN it_PRP is_VBZ evident_JJ that_IN ,_, while_IN heating_VBG a_DT solution_NN of_IN cobra_NN venom_NN at_IN 75¬∞_CD C._NNP for_IN half_PDT an_DT hour_NN ,_, that_WDT is_VBZ to_TO say_VB ,_, so_RB as_IN to_TO coagulate_VB all_DT proteids_NNS coagulable_JJ by_IN heat_NN ,_, does_VBZ not_RB deprive_VB the_DT venom_NN of_IN its_PRP$ anti-clotting_JJ action_NN on_IN the_DT blood_NN ,_, such_JJ heating_NN ,_, nevertheless_RB ,_, diminishes_NNS this_DT particular_JJ physiological_JJ action_NN of_IN the_DT poison_NN to_TO a_DT considerable_JJ extent_NN ._.
For_IN a_DT reference_NN to_TO these_DT two_CD Tables_NNS will_MD show_VB that_IN ,_, while_IN 0¬∑4_CD milligramme_NNS of_IN the_DT unheated_JJ venom_NN suffices_NNS to_TO keep_VB 1_CD c.c_NN ._.
of_IN citrate_NN blood_NN permanently_RB liquid_RBR after_IN the_DT addition_NN of_IN the_DT lime_JJ solution_NN ,_, 0¬∑4_CD milligramme_NN of_IN the_DT heated_JJ venom_NN ,_, from_IN which_WDT the_DT coagulable_JJ proteids_NNS had_VBD been_VBN removed_VBN ,_, delayed_JJ clotting_NN for_IN a_DT considerable_JJ interval_NN of_IN time_NN ,_, but_CC did_VBD not_RB pre-_JJ vent_NN it_PRP from_IN ultimately_RB taking_VBG place_NN ._.
Larger_NNP quantities_NNS of_IN the_DT heated_JJ venom_NN had_VBD a_DT still_RB greater_JJR inhibitory_JJ action_NN on_IN the_DT coagulation_NN of_IN this_DT blood_NN ,_, but_CC even_RB 2_CD milligrammes_NNS did_VBD not_RB completely_RB prevent_JJ clotting_NN ._.
Such_JJ a_DT result_NN would_MD appear_VB to_TO point_VB to_TO the_DT conclusion_NN ,_, that_IN it_PRP is_VBZ not_RB the_DT coagulable_JJ proteids_NNS contained_VBN in_IN cobra_NN venom_NN which_WDT affect_VBP the_DT blood_NN coagulability_NN ,_, but_CC rather_RB some_DT non-coagu-_JJ lable_JJ substance_NN which_WDT ,_, however_RB ,_, is_VBZ considerably_RB diminished_VBN in_IN activity_NN by_IN heating_VBG ._.
This_DT result_NN ,_, therefore_RB ,_, lends_VBZ no_DT support_NN to_TO Martin_NNP 's_POS theory_NN ,_, a_DT conclusion_NN the_DT same_JJ as_IN was_VBD arrived_VBN at_IN with_IN respect_NN to_TO the_DT h√¶molysing_VBG constituent_NN of_IN cobra_NN venom_NN ._.
These_DT two_CD similar_JJ results_NNS ,_, in_IN fact_NN ,_, are_VBP strong_JJ proof_NN against_IN the_DT cor-_JJ rectness_NN of_IN this_DT hypothesis_NN ._.
Such_JJ ,_, then_RB ,_, is_VBZ the_DT effect_NN of_IN the_DT action_NN of_IN cobra_NN venom_NN on_IN the_DT coagulability_NN of_IN citrate_JJ whole_JJ blood_NN ._.
We_PRP may_MD now_RB pass_VB on_IN to_TO the_DT consideration_NN of_IN some_DT similar_JJ experiments_NNS which_WDT were_VBD made_VBN with_IN daboia_JJ venom_NN ._.
We_PRP have_VBP seen_VBN above_IN that_DT daboia_NN venom_NN ,_, injected_VBN into_IN animals_NNS in_IN sufficient_JJ quantity_NN ,_, so_RB increases_VBZ the_DT blood_NN coagulability_NN as_IN to_TO lead_VB to_TO extensive_JJ and_CC rapid_JJ intravascular_JJ clotting_NN ,_, and_CC further_RB that_RB ,_, when_WRB the_DT quantity_NN injected_VBN is_VBZ not_RB suffi-_JJ cient_NN to_TO cause_VB thrombosis_NN ,_, a_DT negative_JJ phase_NN of_IN marked_JJ diminution_NN in_IN the_DT blood_NN coagulability_NN sets_NNS in_IN ._.
As_IN regards_NNS the_DT in_IN vitro_JJ experiments_NNS with_IN citrate_JJ rab-_JJ bit_NN blood_NN ,_, now_RB to_TO be_VB put_VBN on_IN record_NN ,_, it_PRP is_VBZ unnecessary_JJ to_TO detail_VB again_RB the_DT tech-_JJ nique_NN used_VBN ,_, which_WDT was_VBD similar_JJ to_TO that_DT employed_VBN in_IN the_DT experiments_NNS with_IN cobra_JJ venom_NN ._.
But_CC inasmuch_JJ as_IN the_DT first_JJ series_NN of_IN experiments_NNS was_VBD made_VBN with_IN the_DT object_NN of_IN ascertaining_VBG if_IN daboia_JJ venom_NN had_VBD any_DT effect_NN on_IN increasing_VBG the_DT coagula-_JJ bility_NN of_IN citrate_NN blood_NN ,_, it_PRP is_VBZ apparent_JJ that_IN ,_, in_IN order_NN to_TO demonstrate_VB such_PDT an_DT action_NN to_TO the_DT best_JJS advantage_NN ,_, it_PRP was_VBD not_RB feasible_JJ to_TO add_VB the_DT lime_JJ solution_NN to_TO each_DT tube_NN in_IN such_JJ amount_NN as_RB would_MD clot_VB the_DT control_NN in_IN from_IN 2_CD to_TO 3_CD minutes_NNS ._.
17_CD It_PRP was_VBD found_VBN that_IN a_DT good_JJ result_NN was_VBD obtained_VBN by_IN the_DT addition_NN of_IN a_DT very_RB small_JJ amount_NN of_IN calcium_NN chloride_NN ,_, a_DT quantity_NN ,_, in_IN fact_NN ,_, which_WDT did_VBD not_RB clot_VB the_DT control_NN even_RB after_IN six_CD hours_NNS ._.
A_DT reference_NN to_TO Table_NNP X_NNP will_MD show_VB the_DT results_NNS which_WDT were_VBD obtained_VBN by_IN work-_JJ ing_NN in_IN this_DT way_NN ._.
The_DT control_NN tube_NN with_IN a_DT small_JJ quantity_NN of_IN lime_NN added_VBN remained_VBD unclotted_JJ after_IN six_CD hours_NNS ;_: the_DT tubes_NNS to_TO which_WDT from_IN 1_CD to_TO 0¬∑0078_CD milligrammes_NNS of_IN daboia_NN venom_NNS were_VBD added_VBN clotted_VBN solidly_RB in_IN from_IN 5_CD to_TO 10_CD minutes_NNS ;_: and_CC that_IN to_TO which_WDT 0¬∑0002_CD milligramme_NN was_VBD added_VBN clotted_VBN solidly_RB after_IN one_CD hour_NN ._.
We_PRP have_VBP here_RB ,_, then_RB ,_, a_DT perfect_JJ demonstration_NN in_IN vitro_NN of_IN the_DT positive_JJ phase_NN of_IN increased_JJ coagulability_NN caused_VBN by_IN daboia_NN venom_NN ._.
A_DT further_JJ series_NN of_IN experi-_JJ ments_NNS was_VBD then_RB made_VBN with_IN the_DT object_NN of_IN ascertaining_VBG whether_IN or_CC not_RB the_DT nega-_JJ tive_JJ phase_NN of_IN diminished_JJ coagulability_NN could_MD be_VB demonstrated_VBN with_IN citrate_NN blood_NN in_IN vitro_NN ._.
A_DT technique_NN similar_JJ to_TO that_DT used_VBN in_IN the_DT series_NN of_IN experiments_NNS noted_VBN above_IN was_VBD employed_VBN ._.
But_CC much_RB smaller_JJR quantities_NNS of_IN venom_NN were_VBD used_VBN ,_, and_CC the_DT poison_NN was_VBD added_VBN to_TO the_DT blood_NN one_CD hour_NN before_IN the_DT addition_NN of_IN the_DT lime_JJ solution_NN ._.
Further_RB ,_, the_DT quantity_NN of_IN lime_JJ solution_NN added_VBD to_TO each_DT tube_NN was_VBD slightly_RB increased_VBN ,_, so_RB that_IN a_DT clot_NN formed_VBN in_IN the_DT control_NN tube_NN in_IN about_IN four_CD hours_NNS ._.
It_PRP is_VBZ evident_JJ ,_, then_RB ,_, that_IN these_DT conditions_NNS of_IN experimentation_NN were_VBD in_IN every_DT way_NN favourable_JJ to_TO show_VB any_DT diminution_NN in_IN the_DT coagulability_NN of_IN the_DT blood_NN which_WDT the_DT venom_NN might_MD cause_VB ._.
No_DT such_JJ diminution_NN ,_, however_RB ,_, took_VBD place_NN ._.
In_IN fact_NN ,_, quite_RB the_DT opposite_JJ result_NN was_VBD obtained_VBN ._.
For_IN a_DT glance_NN at_IN Table_NNP XI_NNP of_IN the_DT protocols_NNS will_MD show_VB that_DT very_RB minute_JJ quantities_NNS of_IN daboia_NN venom_NN had_VBD a_DT distinct_JJ effect_NN in_IN increasing_VBG the_DT coagulability_NN of_IN citrate_NN blood_NN ,_, even_RB 0¬∑0000009_CD milligramme_NN added_VBD to_TO 1_CD c.c_NN ._.
of_IN citrate_NN blood_NN causing_VBG a_DT slight_JJ shortening_NN of_IN the_DT coagulation_NN time_NN as_IN compared_VBN with_IN the_DT control_NN ._.
A_DT similar_JJ series_NN of_IN experiments_NNS to_TO that_DT recorded_VBN in_IN Table_NNP XI_NNP was_VBD then_RB made_VBN ,_, the_DT only_JJ difference_NN being_VBG that_IN 0¬∑3_CD c.c._NNS ,_, instead_RB of_IN 0¬∑1_CD c.c._NN ,_, of_IN lime_JJ solution_NN (_( 0¬∑5_CD per_IN cent_NN ._. )_)
was_VBD added_VBN to_TO each_DT tube_NN ._.
This_DT amount_NN of_IN lime_NN clotted_VBN the_DT control_NN tube_NN in_IN about_RB two_CD minutes_NNS ._.
As_IN it_PRP was_VBD found_VBN that_IN the_DT contents_NNS of_IN all_PDT the_DT tubes_NNS to_TO which_WDT the_DT venom_NN had_VBD been_VBN added_VBN clotted_VBN in_IN about_IN the_DT same_JJ time_NN as_IN the_DT control_NN ,_, some_DT of_IN them_PRP in_IN fact_NN even_RB more_RBR quickly_RB ,_, this_DT series_NN of_IN experiments_NNS need_MD not_RB be_VB further_RB considered_VBN ._.
It_PRP confirms_VBZ the_DT results_NNS already_RB plainly_RB demonstrated_VBN in_IN Table_NNP XI_NNP ,_, namely_RB ,_, that_IN daboia_NN venom_NN ,_, even_RB in_IN minute_NN quantities_NNS ,_, does_VBZ not_RB cause_VB any_DT diminution_NN in_IN the_DT coagulability_NN of_IN citrate_NN blood_NN in_IN vitro_NN ,_, similar_JJ to_TO the_DT effect_NN which_WDT is_VBZ produced_VBN by_IN cobra_NN venom_NN ._.
This_DT result_NN ,_, therefore_RB ,_, throws_VBZ no_DT light_NN on_IN how_WRB the_DT negative_JJ phase_NN of_IN coagulabil-_JJ ity_NN caused_VBN by_IN daboia_NN venom_NN in_IN vivo_NN is_VBZ brought_VBN about_RB ._.
It_PRP does_VBZ show_VB ,_, how-_JJ ever_RB ,_, that_IN this_DT action_NN of_IN daboia_NN venom_NN is_VBZ something_NN quite_RB different_JJ from_IN the_DT action_NN of_IN cobra_NN venom_NN in_IN this_DT respect_NN ,_, and_CC that_DT ,_, in_IN all_DT probability_NN ,_, it_PRP is_VBZ not_RB due_JJ to_TO a_DT direct_JJ action_NN of_IN the_DT poison_NN on_IN the_DT blood_NN cells_NNS or_CC on_IN the_DT plasma_NN ._.
In_IN the_DT above_JJ experiments_NNS with_IN daboia_JJ venom_FW a_DT small_JJ quantity_NN of_IN soluble_JJ lime_NN salt_NN was_VBD added_VBN to_TO the_DT citrate_NN blood_NN ._.
I_PRP have_VBP now_RB to_TO put_VB forward_RP the_DT results_NNS of_IN some_DT experiments_NNS in_IN which_WDT no_DT lime_NN salt_NN was_VBD added_VBN ,_, daboia_JJ venom_NN alone_RB being_VBG C_NNP 2_CD 18_CD run_NN into_IN each_DT tube_NN of_IN citrate_NN blood_NN ._.
Two_CD series_NN of_IN experiments_NNS of_IN this_DT descrip-_JJ tion_NN are_VBP tabulated_VBN in_IN the_DT protocols_NNS (_( Tables_NNP XII_NNP and_CC XIII_NNP )_) ._.
Firstly_RB ,_, in_IN the_DT series_NN of_IN observations_NNS detailed_VBN in_IN Table_NNP XII_NNP the_DT citrate_NN was_VBD present_JJ in_IN the_DT proportion_NN of_IN 1_CD to_TO 100_CD to_TO the_DT blood_NN ,_, that_WDT is_VBZ to_TO say_VB ,_, the_DT minimum_NN amount_NN which_WDT can_MD be_VB depended_VBN on_IN to_TO keep_VB rabbit_NN 's_POS blood_NN permanently_RB liquid.33_VBZ A_DT reference_NN to_TO this_DT table_NN will_MD show_VB that_IN 0¬∑5_CD milligramme_NN of_IN venom_NN clotted_VBD 1_CD c.c_NN ._.
of_IN the_DT citrate_NN blood_NN in_IN a_DT little_JJ over_RP half_PDT an_DT hour_NN ,_, and_CC 0¬∑0312_CD milligramme_NN in_IN about_RB two_CD hours_NNS ._.
Smaller_NNP quantities_NNS than_IN this_DT caused_JJ no_DT clot_NN in_IN two_CD hours_NNS ._.
Secondly_RB ,_, in_IN the_DT series_NN of_IN experiments_NNS detailed_VBN in_IN Table_NNP XIII_NNP of_IN the_DT proto-_JJ cols_VBZ the_DT citrate_NN was_VBD present_JJ in_IN the_DT proportion_NN of_IN 1_CD to_TO 50_CD to_TO the_DT blood_NN ,_, namely_RB ,_, a_DT quantity_NN double_RB the_DT amount_NN which_WDT is_VBZ necessary_JJ to_TO keep_VB rabbit_NN 's_POS blood_NN unclotted_VBD in_IN vitro_NN ._.
Under_IN this_DT condition_NN it_PRP was_VBD found_VBN that_IN 2_CD milligrammes_NNS of_IN venom_NNS were_VBD required_VBN to_TO cause_VB clotting_NN of_IN 1_CD c.c_NN ._.
of_IN blood_NN in_IN half_PDT an_DT hour_NN ,_, that_IN 0¬∑6_CD milli-_JJ gramme_NN caused_VBD clotting_VBG only_RB after_IN 1¬æ_CD hours_NNS ,_, and_CC that_IN 0¬∑2_CD milligramme_NNS caused_VBD only_RB a_DT slight_JJ clot_NN after_IN 2_CD hours_NNS ._.
Thus_RB ,_, it_PRP is_VBZ seen_VBN that_IN the_DT presence_NN of_IN an_DT excess_NN of_IN citrate_NN ,_, while_IN not_RB preventing_VBG the_DT clotting_VBG action_NN of_IN the_DT venom_NN ,_, certainly_RB lessens_VBZ this_DT power_NN to_TO some_DT extent_NN ._.
The_DT results_NNS ,_, then_RB ,_, of_IN these_DT two_CD series_NN of_IN experiments_NNS ,_, taken_VBN with_IN the_DT results_NNS of_IN the_DT two_CD series_NN detailed_VBN in_IN Tables_NNP X_NNP and_CC XI_NNP ,_, show_VBP that_IN daboia_NN venom_NN can_MD of_IN itself_PRP cause_VBP clotting_VBG of_IN well_RB citrated_VBN blood_NN in_IN vitro_NN ,_, but_CC that_IN the_DT clotting_NN is_VBZ more_RBR rapid_JJ and_CC the_DT clot_NN is_VBZ firmer_JJR ,_, the_DT nearer_NN the_DT quantity_NN of_IN lime_NN salts_NNS in_IN solution_NN in_IN the_DT blood_NN approaches_NNS to_TO that_DT contained_VBN in_IN normal_JJ blood_NN ._.
I_PRP do_VBP not_RB for_IN a_DT moment_NN urge_NN that_WDT daboia_VBZ venom_NN of_IN itself_PRP is_VBZ able_JJ to_TO cause_VB clotting_NN of_IN blood_NN which_WDT contains_VBZ no_DT lime_NN salt_NN in_IN solution_NN ,_, as_IN the_DT citrate_NN of_IN lime_NN is_VBZ not_RB an_DT absolutely_RB insoluble_JJ salt_NN ._.
However_RB ,_, the_DT fact_NN that_IN daboia_VBZ ve-_JJ nom_NN does_VBZ of_IN itself_PRP clot_VBP citrate_JJ blood_NN in_IN vitro_NN is_VBZ important_JJ and_CC interesting_JJ ,_, as_IN I_PRP know_VBP of_IN no_DT other_JJ substance_NN which_WDT has_VBZ this_DT action_NN without_IN the_DT addition_NN of_IN a_DT small_JJ quantity_NN of_IN soluble_JJ lime_JJ salt_NN ._.
In_IN a_DT recent_JJ paper_NN by_IN Dr._NNP Hanna_NNP and_CC myself_PRP ,_, 34_CD we_PRP pointed_VBD out_RP the_DT fact_NN that_IN heating_VBG a_DT weak_JJ solution_NN of_IN daboia_NN venom_NN completely_RB destroys_VBZ the_DT property_NN which_WDT this_DT poison_NN has_VBZ of_IN causing_VBG any_DT increase_NN of_IN the_DT blood_NN coagulability_NN in_IN vivo_NN ._.
We_PRP showed_VBD that_IN after_IN heating_VBG a_DT 0¬∑1_CD per_IN cent_NN ._.
solution_NN for_IN half_PDT an_DT hour_NN at_IN 75¬∞_CD C._NNP a_DT large_JJ quantity_NN of_IN the_DT filtrate_NN can_MD be_VB introduced_VBN into_IN the_DT blood_NN stream_NN of_IN animals_NNS without_IN causing_VBG any_DT symptoms_NNS ._.
I_PRP have_VBP found_VBN that_IN a_DT comparable_JJ result_NN is_VBZ obtained_VBN with_IN citrate_JJ blood_NN in_IN vitro_NN ,_, that_WDT is_VBZ to_TO say_VB ,_, heating_VBG a_DT weak_JJ solution_NN of_IN daboia_NN venom_NN at_IN 75¬∞_CD C._NNP for_IN half_PDT an_DT hour_NN completely_RB destroys_VBZ the_DT clotting_VBG action_NN the_DT unheated_JJ venom_NN has_VBZ on_IN cit-_JJ rate_NN blood_NN ._.
Such_JJ an_DT experiment_NN is_VBZ detailed_VBN in_IN Table_NNP XIV_NNP of_IN the_DT protocols_NNS ._.
From_IN this_DT Table_NN it_PRP will_MD be_VB seen_VBN that_IN even_RB 2_CD milligrammes_NNS of_IN venom_NN (_( 0¬∑2_CD per_IN cent_NN ._.
solution_NN )_) ,_, heated_VBN for_IN half_PDT an_DT hour_NN at_IN 75¬∞_CD C._NNP ,_, does_VBZ not_RB clot_VB 1_CD c.c_NN ._.
of_IN citrate_NN blood_NN after_IN 3_CD hours_NNS ._.
When_WRB we_PRP consider_VBP that_DT 0¬∑03_CD milligramme_NN of_IN the_DT unheated_JJ venom_NN clots_NNS in_IN 2_CD hours_NNS this_DT amount_NN of_IN blood_NN ,_, citrated_VBD to_TO the_DT same_JJ extent_NN ,_, we_PRP must_MD 19_CD conclude_NN that_IN heating_VBG in_IN this_DT way_NN completely_RB destroys_VBZ this_DT constituent_NN of_IN the_DT poison_NN ._.
I_PRP have_VBP shown_VBN above_IN that_IN it_PRP is_VBZ not_RB possible_JJ ,_, even_RB with_IN minute_JJ quantities_NNS of_IN venom_NN ,_, to_TO demonstrate_VB in_IN vitro_NN the_DT negative_JJ phase_NN of_IN diminution_NN of_IN blood_NN coagulability_NN ,_, which_WDT negative_JJ phase_NN is_VBZ such_JJ a_DT marked_JJ phenomenon_NN in_IN chronic_JJ cases_NNS of_IN daboia_JJ intoxication_NN ._.
I_PRP have_VBP also_RB shown_VBN in_IN the_DT case_NN of_IN cobra_NN venom_NN that_IN a_DT marked_JJ diminution_NN in_IN the_DT blood_NN coagulability_NN produced_VBN by_IN this_DT poison_NN is_VBZ capable_JJ of_IN demonstration_NN both_DT in_IN vivo_NN and_CC in_IN vitro_NN ._.
It_PRP was_VBD thought_VBN that_IN the_DT failure_NN of_IN daboia_NN venom_NN to_TO cause_VB diminished_JJ coagulability_NN of_IN the_DT blood_NN in_IN vitro_NN might_MD possibly_RB be_VB due_JJ to_TO the_DT fact_NN ,_, that_IN the_DT constituent_NN of_IN this_DT poison_NN which_WDT causes_VBZ clotting_NN is_VBZ a_DT different_JJ substance_NN to_TO that_DT which_WDT causes_VBZ the_DT diminution_NN of_IN coagula-_JJ bility_NN in_IN vivo_NN and_CC that_IN this_DT latter_NN is_VBZ not_RB able_JJ to_TO exert_VB its_PRP$ specific_JJ action_NN in_IN vitro_NN in_IN the_DT presence_NN of_IN the_DT former_JJ ._.
Now_RB ,_, we_PRP have_VBP seen_VBN that_IN heating_VBG a_DT weak_JJ solution_NN of_IN cobra_NN venom_NN diminishes_NNS ,_, but_CC does_VBZ not_RB destroy_VB ,_, the_DT power_NN which_WDT ,_, this_DT poison_NN has_VBZ to_TO prevent_VB coagulation_NN of_IN citrate_NN blood_NN in_IN vitro_NN ,_, while_IN heating_VBG a_DT solution_NN of_IN daboia_NN venom_NN completely_RB destroys_VBZ its_PRP$ power_NN to_TO cause_VB an_DT increase_NN of_IN coagulability_NN ._.
If_IN the_DT above_JJ hypothesis_NN were_VBD correct_JJ ,_, then_RB it_PRP would_MD be_VB found_VBN that_IN by_IN heating_VBG a_DT weak_JJ solution_NN of_IN daboia_NN venom_NN ,_, thereby_RB completely_RB destroying_VBG the_DT constituent_NN which_WDT causes_VBZ coagulation_NN of_IN citrate_NN blood_NN ,_, the_DT heated_JJ poison_NN would_MD have_VB the_DT effect_NN of_IN completely_RB inhibiting_VBG or_CC diminishing_VBG the_DT coagulability_NN of_IN citrate_NN blood_NN ._.
This_DT theory_NN ,_, however_RB ,_, was_VBD not_RB supported_VBN by_IN experimental_JJ data_NNS ._.
For_IN a_DT reference_NN to_TO Table_NNP XV_NNP of_IN the_DT protocols_NNS will_MD show_VB that_IN 2_CD milligrammes_NNS of_IN daboia_NN venom_NN ,_, heated_VBN in_IN weak_JJ solution_NN ,_, after_IN being_VBG in_IN contact_NN with_IN 1_CD c.c_NNS ._.
of_IN citrate_NN blood_NN for_IN 3_CD hours_NNS ,_, had_VBD no_DT effect_NN of_IN lengthening_VBG the_DT coagula-_JJ tion_NN time_NN of_IN the_DT blood_NN ,_, when_WRB a_DT quantity_NN of_IN lime_JJ solution_NN sufficient_NN to_TO clot_VB the_DT control_NN in_IN about_RB 2_CD minutes_NNS was_VBD added_VBN ._.
This_DT result_NN ,_, then_RB ,_, strongly_RB supports_VBZ the_DT conclusion_NN I_PRP have_VBP already_RB put_VBN forward_RB on_IN page_NN 17_CD ,_, namely_RB ,_, that_IN the_DT sub-_JJ stance_NN in_IN daboia_NN venom_NN ,_, which_WDT causes_VBZ the_DT diminution_NN of_IN coagulability_NN in_IN vivo_NN ,_, differs_NNS both_DT in_IN nature_NN and_CC in_IN method_NN of_IN action_NN from_IN the_DT substance_NN in_IN cobra_NN venom_NN ,_, which_WDT has_VBZ such_PDT a_DT marked_JJ inhibitory_JJ effect_NN on_IN the_DT blood_NN coagulability_NN both_DT in_IN vivo_NN and_CC in_IN vitro_NN ._.
Further_RB ,_, it_PRP is_VBZ evident_JJ that_IN the_DT observations_NNS on_IN the_DT action_NN of_IN daboia_NN venom_NN on_IN the_DT coagulability_NN of_IN the_DT blood_NN in_IN vitro_NN neither_CC support_NN nor_CC disprove_VB Martin_NNP 's_POS hypothesis_NN ,_, namely_RB ,_, that_IN the_DT constituent_NN of_IN all_DT snake_NN venoms_NNS which_WDT acts_VBZ as_IN a_DT blood_NN poison_NN is_VBZ a_DT proteid_NN coagulable_JJ by_IN heat_NN ._.
Finally_RB ,_, when_WRB we_PRP consider_VBP the_DT results_NNS of_IN all_PDT the_DT observations_NNS with_IN cobra_NN and_CC daboia_NN venom_NN detailed_VBN above_RB ,_, there_EX can_MD be_VB no_DT possible_JJ doubt_NN that_IN in_IN their_PRP$ action_NN on_IN the_DT cell_NN constituents_NNS of_IN the_DT blood_NN and_CC on_IN the_DT blood_NN plasma_NN ,_, the_DT differences_NNS between_IN these_DT two_CD venoms_NNS are_VBP fundamental_JJ differences_NNS ,_, and_CC not_RB only_RB differences_NNS in_IN degree_NN of_IN toxicity_NN ._.
These_DT observations_NNS ,_, in_IN short_JJ ,_, support_VB my_PRP$ contention_NN ,_, that_IN Calmette_NNP 's_POS statement_NN ,_, that_IN all_DT snake_NN venoms_NNS are_VBP alike_RB in_IN their_PRP$ physiological_JJ actions_NNS ,_, is_VBZ quite_RB wrong_JJ and_CC evidently_RB not_RB founded_VBN on_IN experimental_JJ data_NNS carefully_RB worked_VBD out_RP ._.
20_CD The_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN the_DT coagulability_NN of_IN citrate_NN and_CC oxalate_JJ plasma_NN ._.
We_PRP may_MD now_RB pass_VB on_IN to_TO consider_VB whether_IN or_CC not_RB results_NNS ,_, similar_JJ to_TO those_DT which_WDT have_VBP been_VBN collated_VBN above_IN in_IN the_DT case_NN of_IN citrate_JJ whole_JJ blood_NN ,_, can_MD also_RB be_VB obtained_VBN with_IN citrate_NN or_CC oxalate_NN plasma_NN which_WDT has_VBZ been_VBN freed_VBN from_IN red_JJ cells_NNS by_IN a_DT process_NN of_IN sedimentation_NN ._.
The_DT importance_NN of_IN such_JJ an_DT investigation_NN is_VBZ evi-_JJ dent_NN in_IN view_NN of_IN the_DT theory_NN put_VBN forward_RB by_IN Martin_NNP (_( page_VB 10_CD )_) ,_, namely_RB ,_, that_IN the_DT action_NN of_IN snake_NN venoms_NNS on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN probably_RB depends_VBZ on_IN the_DT fact_NN that_RB ,_, as_IN a_DT result_NN of_IN a_DT great_JJ destruction_NN of_IN cells_NNS ,_, especially_RB of_IN the_DT red_JJ cells_NNS of_IN the_DT blood_NN ,_, by_IN the_DT poison_NN ,_, a_DT large_JJ quantity_NN of_IN nucleo-proteids_NNS is_VBZ set_VBN free_JJ and_CC that_IN it_PRP is_VBZ these_DT nucleo-proteids_NNS which_WDT affect_VBP the_DT blood_NN coagulability_NN ._.
Some_DT of_IN the_DT experiments_NNS detailed_VBN below_IN were_VBD made_VBN along_IN with_IN Professor_NNP Martin_NNP ,_, to_TO whom_WP I_PRP am_VBP indebted_VBN for_IN much_JJ valuable_JJ suggestion_NN and_CC encourage-_JJ ment_NN ._.
In_IN these_DT experiments_NNS the_DT same_JJ samples_NNS of_IN citrate_NN and_CC oxalate_JJ plasma_NN were_VBD used_VBN throughout_IN ,_, so_IN that_IN it_PRP will_MD suffice_VB once_RB for_IN all_DT to_TO give_VB a_DT short_JJ description_NN of_IN the_DT manner_NN in_IN which_WDT these_DT were_VBD obtained_VBN and_CC kept_VBN ._.
They_PRP were_VBD both_DT got_VBN from_IN the_DT horse_NN ._.
In_IN the_DT case_NN of_IN the_DT citrate_NN plasma_NN one_CD litre_NN of_IN blood_NN was_VBD drawn_VBN into_IN 50_CD c.c_NN ._.
of_IN a_DT 20_CD per_IN cent_NN ._.
solution_NN of_IN citrate_NN of_IN soda_NN (_( 0.75_CD per_IN cent_NN ,_, saline_JJ solution_NN )_) ,_, that_WDT is_VBZ to_TO say_VB ,_, there_EX was_VBD I_PRP per_IN cent_NN ._.
citrate_NN in_IN the_DT whole_JJ blood_NN ._.
This_DT was_VBD kept_VBN in_IN an_DT ice_NN chest_NN (_( temperature_NN about_IN 14¬∞_CD C._NNP )_) for_IN 48_CD hours_NNS ._.
Then_RB the_DT supernatant_NN plasma_NN was_VBD syphoned_VBN off_RP into_IN small_JJ bottles_NNS ,_, which_WDT were_VBD stored_VBN in_IN an_DT ice_NN chest_NN till_NN required_VBN ._.
In_IN the_DT case_NN of_IN the_DT oxalate_NN plasma_NN one_CD litre_NN of_IN blood_NN was_VBD drawn_VBN into_IN 40_CD c.c_NN ._.
of_IN a_DT 5_CD per_IN cent_NN ._.
solution_NN of_IN oxalate_NN of_IN potash_NN (_( 0.75_CD per_IN cent_NN ,_, saline_JJ solution_NN )_) ,_, that_WDT is_VBZ to_TO say_VB ,_, there_EX was_VBD 0.2_CD per_IN cent_NN ._.
oxalate_NN in_IN the_DT whole_JJ blood_NN ._.
This_DT was_VBD then_RB treated_VBN in_IN exactly_RB the_DT same_JJ way_NN as_IN the_DT citrate_NN blood_NN ._.
The_DT plasma_NN was_VBD likewise_RB stored_VBN in_IN the_DT ice_NN chest_NN till_NN required_VBN ._.
Strict_NNP aseptic_JJ precautions_NNS were_VBD observed_VBN in_IN the_DT collection_NN and_CC storing_NN of_IN these_DT samples_NNS of_IN plasma_NN ._.
Just_RB before_RB use_NN in_IN both_DT cases_NNS the_DT bottles_NNS were_VBD well_RB shaken_VBN up_RP and_CC heated_VBN in_IN an_DT oven_NN at_IN 37¬∞_CD C._NNP for_IN a_DT short_JJ time_NN ._.
The_DT next_JJ step_NN was_VBD to_TO determine_VB the_DT amount_NN of_IN soluble_JJ lime_NN salt_NN which_WDT it_PRP was_VBD necessary_JJ to_TO add_VB to_TO a_DT given_VBN quantity_NN of_IN each_DT plasma_NN to_TO procure_VB rapid_JJ and_CC firm_JJ clotting_NN ._.
To_TO save_VB repetition_NN it_PRP may_MD be_VB stated_VBN here_RB that_IN in_IN all_DT these_DT experi-_JJ ments_NNS 2_CD c.c_NN ._.
of_IN plasma_NN was_VBD the_DT amount_NN run_VB into_IN each_DT tube_NN ,_, and_CC that_IN a_DT 1_CD per_IN cent_NN ._.
solution_NN of_IN calcium_NN chloride_NN was_VBD employed_VBN as_IN the_DT lime_JJ solution_NN ._.
The_DT results_NNS of_IN this_DT estimation_NN are_VBP detailed_VBN in_IN Table_NNP XVI_NNP of_IN the_DT protocols_NNS ._.
From_IN this_DT Table_NN it_PRP will_MD be_VB seen_VBN that_IN 0.5_CD c.c_NN ._.
of_IN the_DT lime_JJ solution_NN clotted_VBD 2_CD c.c_NN ._.
of_IN citrate_NN plasma_NN in_IN less_JJR than_IN 8_CD minutes_NNS ,_, and_CC that_IN 0.4_CD c.c_NN ._.
of_IN lime_JJ solution_NN clot-_NN ted_VBD 2_CD c.c_NN ._.
of_IN oxalate_JJ plasma_NN in_IN to_TO minutes_NNS ._.
These_DT ,_, then_RB ,_, were_VBD the_DT quantities_NNS of_IN lime_JJ solution_NN used_VBN in_IN the_DT experiments_NNS with_IN cobra_JJ venom_NN ._.
Having_VBG by_IN preliminary_JJ observation_NN ascertained_VBD that_IN cobra_NN venom_NN did_VBD 21_CD prevent_NN clotting_NN of_IN both_DT citrate_NN and_CC oxalate_NN plasma_NN ,_, I_PRP next_RB proceeded_VBD to_TO estimate_VB the_DT amount_NN of_IN venom_NN which_WDT was_VBD able_JJ to_TO effect_NN this_DT ,_, when_WRB added_VBN to_TO the_DT plasma_NN 2_CD hours_NNS before_IN the_DT addition_NN of_IN the_DT quantity_NN of_IN lime_JJ solution_NN sufficient_NN to_TO cause_VB clotting_NN of_IN the_DT control_NN in_IN a_DT few_JJ minutes_NNS ._.
The_DT results_NNS of_IN these_DT estimations_NNS are_VBP detailed_VBN in_IN Tables_NNP XVII_NNP and_CC XVIII_NNP of_IN the_DT protocols_NNS ._.
In_IN the_DT case_NN of_IN citrate_NN plasma_NN (_( Table_NNP XVII_NNP )_) it_PRP was_VBD found_VBN that_IN I_PRP milligramme_VBP of_IN cobra_NN venom_NN was_VBD sufficient_JJ to_TO keep_VB 2_CD c.c_NN ._.
of_IN plasma_JJ perma-_JJ nently_RB liquid_NN ,_, and_CC that_IN amounts_NNS less_JJR than_IN this_DT ,_, down_RB to_TO 0.2_CD milligramme_NN ,_, had_VBD a_DT very_RB marked_JJ inhibitory_JJ action_NN on_IN coagulation_NN ,_, the_DT clot_NN which_WDT had_VBD formed_VBN after_IN 20_CD hours_NNS being_VBG always_RB soft_JJ and_CC loose_JJ ._.
The_DT control_NN ,_, with_IN the_DT same_JJ amount_NN of_IN lime_NN as_IN the_DT venom_NN tubes_NNS ,_, clotted_VBD solidly_RB in_IN a_DT few_JJ minutes_NNS ._.
The_DT similarity_NN between_IN this_DT result_NN and_CC that_DT detailed_VBD in_IN Table_NNP VII_NNP ,_, the_DT series_NN of_IN experiments_NNS in_IN which_WDT citrate_VBP whole_JJ blood_NN was_VBD used_VBN ,_, allowance_NN being_VBG made_VBN for_IN the_DT plasma_NN being_VBG double_JJ the_DT amount_NN of_IN the_DT whole_JJ blood_NN ,_, is_VBZ striking_VBG and_CC worthy_JJ of_IN note_NN ._.
In_IN the_DT case_NN of_IN oxalate_NN plasma_NN (_( Table_NNP XVIII_NNP )_) it_PRP was_VBD found_VBN that_IN even_RB 0.2_CD milligramme_NN of_IN cobra_NN venom_NN was_VBD able_JJ to_TO keep_VB 2_CD c._JJ c._NN of_IN plasma_NN unclotted_VBN for_IN a_DT period_NN of_IN at_IN least_JJS 20_CD hours_NNS ._.
The_DT control_NN ,_, with_IN the_DT same_JJ quantity_NN of_IN lime_NN added_VBN ,_, clotted_VBN solidly_RB in_IN 10_CD minutes_NNS ._.
These_DT results_NNS ,_, then_RB ,_, confirm_NN and_CC further_JJ extend_VBP the_DT observations_NNS with_IN citrate_JJ whole_JJ blood_NN ,_, which_WDT I_PRP have_VBP already_RB recorded_VBN ._.
They_PRP show_VBP that_IN the_DT h√¶molytic_JJ action_NN of_IN cobra_NN venom_NN is_VBZ quite_RB independent_JJ of_IN its_PRP$ action_NN in_IN inhibiting_VBG coagulation_NN ,_, that_DT ,_, in_IN fact_NN ,_, the_DT action_NN which_WDT this_DT poison_NN has_VBZ on_IN the_DT blood_NN coagula-_JJ bility_NN does_VBZ not_RB depend_VB on_IN the_DT destructive_JJ effect_NN which_WDT it_PRP has_VBZ on_IN the_DT red_JJ blood_NN corpuscles_NNS and_CC other_JJ cells_NNS ._.
It_PRP would_MD ,_, therefore_RB ,_, appear_VBP certain_JJ that_IN the_DT action_NN of_IN one_CD venom_NN at_IN any_DT rate_NN ,_, namely_RB ,_, cobra_NN venom_NN ,_, on_IN the_DT blood_NN coagulation_NN in_IN vivo_NN can_MD not_RB be_VB explained_VBN by_IN Martin_NNP 's_POS hypothesis_NN ,_, that_WDT is_VBZ to_TO say_VB ,_, the_DT setting_VBG free_JJ of_IN nucleo-proteids_NNS as_IN a_DT result_NN of_IN the_DT great_JJ destruction_NN of_IN the_DT cells_NNS of_IN the_DT body_NN in_IN general_JJ ,_, and_CC of_IN the_DT red_JJ cells_NNS in_IN particular_JJ ,_, which_WDT is_VBZ caused_VBN by_IN this_DT poison_NN ._.
It_PRP can_MD not_RB ,_, however_RB ,_, be_VB said_VBD from_IN these_DT experiments_NNS that_IN nucleo-proteids_JJ play_NN no_DT part_NN in_IN this_DT phenomenon_NN ,_, as_IN plasma_NN prepared_VBN in_IN the_DT manner_NN I_PRP have_VBP described_VBN is_VBZ rich_JJ in_IN these_DT substances_NNS ,_, derived_VBN ,_, as_IN they_PRP are_VBP ,_, from_IN disintegra-_JJ tion_NN of_IN the_DT white_JJ cells_NNS of_IN the_DT blood_NN after_IN its_PRP$ withdrawal_NN from_IN the_DT vessels_NNS ._.
With_IN the_DT view_NN of_IN further_JJ investigating_VBG this_DT action_NN of_IN cobra_NN venom_NN ,_, two_CD series_NN of_IN experiments_NNS were_VBD made_VBN with_IN a_DT sample_NN of_IN hydrocele_JJ fluid_NN ._.
This_DT sample_NN did_VBD not_RB clot_VB on_IN the_DT addition_NN of_IN a_DT soluble_JJ lime_NN salt_NN ,_, but_CC was_VBD clotted_VBN solidly_RB by_IN the_DT addition_NN ,_, either_CC with_IN or_CC without_IN a_DT small_JJ amount_NN of_IN lime_NN ,_, of_IN a_DT small_JJ quantity_NN of_IN citrate_NN donkey_NN plasma_NN (_( 1_CD per_IN cent_NN ._. )_) ._.
It_PRP was_VBD found_VBN that_IN 0.1_CD c.c_NN ._.
of_IN this_DT plasma_NN clotted_VBD 2_CD c.c_NN ._.
of_IN hydrocele_JJ fluid_NN in_IN about_IN 20_CD minutes_NNS ._.
A_DT reference_NN to_TO Tables_NNP XIX_NNP and_CC XX_NNP of_IN the_DT protocols_NNS will_MD show_VB that_IN even_RB 0.1_CD milligramme_NN of_IN cobra_NN venom_NN was_VBD sufficient_JJ to_TO inhibit_VB completely_RB the_DT clotting_NN of_IN this_DT sample_NN of_IN hydrocele_NN fluid_NN ,_, as_IN brought_VBN about_IN by_IN the_DT addition_NN of_IN a_DT small_JJ amount_NN of_IN citrate_NN plasma_NN ,_, when_WRB the_DT venom_NN was_VBD allowed_VBN to_TO act_VB on_IN the_DT plasma_NN for_IN 10_CD minutes_NNS before_IN the_DT addition_NN [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75023956.tif_CD ]_JJ 22_CD of_IN the_DT hydrocele_NN fluid_NN ._.
The_DT addition_NN of_IN a_DT small_JJ quantity_NN of_IN soluble_JJ lime_JJ salt_NN did_VBD not_RB affect_VB this_DT result_NN in_IN any_DT way_NN ._.
Taking_VBG these_DT observations_NNS along_IN with_IN the_DT others_NNS already_RB recorded_VBN ,_, into_IN consideration_NN ,_, I_PRP can_MD only_RB conclude_VB that_IN cobra_NN venom_NN owes_VBZ its_PRP$ anti-clotting_JJ power_NN either_DT to_TO some_DT obscure_JJ chemical_JJ combina-_NN tion_NN which_WDT it_PRP effects_NNS with_IN the_DT nucleo-proteids_NNS ,_, rendering_VBG these_DT substances_NNS inert_VBP as_RB far_RB as_IN coagulation_NN is_VBZ concerned_VBN ,_, or_CC to_TO an_DT action_NN of_IN a_DT destructive_JJ nature_NN on_IN the_DT hypothetical_JJ fibrin_NN ferment_NN contained_VBN in_IN plasma_NN ._.
I_PRP have_VBP been_VBN unable_JJ ,_, so_RB far_RB ,_, to_TO obtain_VB nucleo-proteids_NNS ,_, except_IN as_RB contained_VBN in_IN plasma_NN ,_, which_WDT were_VBD able_JJ to_TO cause_VB clotting_NN of_IN any_DT sample_NN of_IN hydrocele_NN fluid_NN which_WDT I_PRP could_MD procure_VB ._.
It_PRP is_VBZ impossible_JJ ,_, therefore_RB ,_, to_TO exclude_VB the_DT action_NN which_WDT the_DT venom_NN may_MD have_VB on_IN any_DT ferment_NN which_WDT may_MD be_VB contained_VBN in_IN plasma_NN ._.
Further_JJ experiments_NNS are_VBP ,_, however_RB ,_, in_IN progress_NN and_CC will_MD form_VB the_DT subject_NN of_IN another_DT communication_NN ._.
I_PRP may_MD now_RB pass_VB on_IN to_TO put_VB on_IN record_NN some_DT experiments_NNS ,_, which_WDT bear_VBP on_IN the_DT action_NN which_WDT daboia_NN venom_NN has_VBZ on_IN the_DT coagulability_NN of_IN citrate_NN and_CC oxalate_NN plasma_NN in_IN vitro_NN ._.
As_IN the_DT same_JJ samples_NNS of_IN plasma_NN as_IN were_VBD employed_VBN for_IN the_DT experiments_NNS with_IN cobra_JJ venom_NNS were_VBD used_VBN for_IN these_DT experiments_NNS ,_, it_PRP is_VBZ unnecessary_JJ to_TO again_RB detail_VB the_DT method_NN of_IN their_PRP$ preparation_NN ._.
We_PRP have_VBP already_RB seen_VBN (_( Tables_NNP X_NNP to_TO XV_VB )_) that_IN daboia_NN venom_NN has_VBZ a_DT marked_VBN action_NN on_IN the_DT coagulability_NN of_IN citrate_JJ whole_JJ blood_NN ._.
It_PRP has_VBZ been_VBN demonstrated_VBN that_IN it_PRP can_MD ,_, even_RB without_IN the_DT addition_NN of_IN any_DT soluble_JJ lime_NN salt_NN ,_, produce_VBP solid_JJ clotting_NN of_IN citrate_JJ whole_JJ blood_NN and_CC ,_, further_RB ,_, that_IN it_PRP contains_VBZ no_DT substance_NN strictly_RB analogous_JJ to_TO the_DT substance_NN contained_VBN in_IN cobra_NN venom_NN ,_, a_DT substance_NN which_WDT has_VBZ such_PDT a_DT remarkable_JJ power_NN of_IN completely_RB inhibiting_VBG the_DT coagulation_NN of_IN citrate_NN blood_NN as_IN brought_NN about_IN by_IN the_DT addition_NN of_IN a_DT soluble_JJ lime_NN salt_NN ._.
Three_CD series_NN of_IN experiments_NNS were_VBD made_VBN with_IN daboia_JJ venom_NN and_CC citrate_NN and_CC oxalate_JJ plasma_NN ._.
In_IN the_DT first_JJ series_NN varying_VBG quantities_NNS of_IN the_DT venom_NN alone_RB were_VBD added_VBN to_TO a_DT series_NN of_IN tubes_JJ each_DT containing_VBG 2_CD c.c_NN ._.
of_IN citrate_NN plasma_NN ._.
A_DT reference_NN to_TO the_DT protocols_NNS (_( Table_NNP XXI_NNP )_) will_MD show_VB that_RB ,_, as_IN in_IN the_DT case_NN of_IN citrate_JJ whole_JJ blood_NN ,_, daboia_NN venom_NN causes_VBZ clotting_VBG of_IN citrate_NN plasma_NN without_IN the_DT addition_NN of_IN any_DT lime_NN ._.
Thus_RB any_DT quantity_NN of_IN venom_NN from_IN 3_CD to_TO 5_CD milligrammes_NNS clotted_VBD 2_CD c.c_NN ._.
of_IN plasma_NN in_IN less_JJR than_IN 3_CD hours_NNS :_: with_IN an_DT amount_NN between_IN 0.4_CD and_CC 1_CD milligramme_NN clotting_NN occurred_VBD ,_, but_CC was_VBD delayed_VBN for_IN about_RB 20_CD hours_NNS ,_, while_IN 0.2_CD milligramme_NNS caused_VBD only_RB a_DT slight_JJ clot_NN after_IN 20_CD hours_NNS ._.
The_DT second_JJ series_NN of_IN experiments_NNS (_( Table_NNP XXII_NNP )_) was_VBD similar_JJ to_TO the_DT above_JJ series_NN ,_, only_RB oxalate_JJ plasma_NN was_VBD substituted_VBN for_IN citrate_NN plasma_NN ._.
The_DT results_NNS obtained_VBD show_NN that_IN daboia_VBZ venom_JJ causes_NNS very_RB slight_JJ clotting_NN of_IN plasma_NN of_IN this_DT nature_NN ,_, for_IN even_RB 5_CD milligrammes_NNS of_IN venom_NN produced_VBN only_RB a_DT feeble_JJ clot_NN in_IN 2_CD c.c_NN ._.
of_IN plasma_NN after_IN 20_CD hours_NNS ;_: smaller_JJR amounts_NNS down_IN to_TO 0.6_CD milligramme_NN had_VBD the_DT same_JJ effect_NN ;_: while_IN 0.4_CD milligramme_NNS produced_VBD no_DT clotting_NN at_IN all_DT ._.
The_DT third_JJ series_NN of_IN experiments_NNS was_VBD made_VBN with_IN the_DT object_NN of_IN ascertaining_VBG 23_CD the_DT reason_NN of_IN this_DT difference_NN between_IN citrate_NN and_CC oxalate_JJ plasma_NN ._.
In_IN this_DT series_NN (_( Table_NNP XXIII_NNP )_) to_TO each_DT tube_NN of_IN oxalate_NN plasma_NN ,_, at_IN the_DT same_JJ time_NN as_IN the_DT daboia_NN venom_NN was_VBD added_VBN ,_, there_EX was_VBD run_VBN in_IN a_DT small_JJ amount_NN of_IN soluble_JJ lime_NN salt_NN ,_, an_DT amount_NN ,_, however_RB ,_, not_RB sufficient_JJ to_TO clot_VB the_DT control_NN in_IN 20_CD hours_NNS ._.
As_IN a_DT result_NN of_IN this_DT addition_NN of_IN lime_NN the_DT contents_NNS of_IN each_DT tube_NN clotted_VBD solidly_RB in_IN about_RB 10_CD minutes_NNS ._.
It_PRP is_VBZ ,_, therefore_RB ,_, apparent_NN that_IN the_DT failure_NN of_IN daboia_NN venom_NN to_TO produce_VB solid_JJ clotting_NN of_IN oxalate_NN plasma_NNS ,_, while_IN it_PRP does_VBZ clot_VB citrate_VB plasma_NN ,_, is_VBZ due_JJ to_TO the_DT fact_NN that_IN the_DT oxalate_NN of_IN lime_NN is_VBZ a_DT more_RBR insoluble_JJ salt_NN than_IN the_DT citrate_NN ._.
The_DT coagulation_NN of_IN plasma_NN by_IN daboia_JJ venom_NN does_VBZ not_RB take_VB place_NN independently_RB of_IN a_DT certain_JJ amount_NN of_IN lime_JJ salt_NN in_IN solution_NN ._.
The_DT venom_NN acts_VBZ ,_, evidently_RB ,_, by_IN increasing_VBG the_DT coagulability_NN of_IN the_DT plasma_NN ,_, but_CC solid_JJ formation_NN of_IN clot_NN can_MD not_RB take_VB place_NN unless_IN a_DT small_JJ quantity_NN of_IN lime_NN in_IN solution_NN ,_, in_IN some_DT form_NN or_CC other_JJ ,_, is_VBZ present_JJ as_RB well_RB ._.
With_IN a_DT view_NN of_IN further_JJ searching_VBG for_IN a_DT working_JJ hypothesis_NN to_TO explain_VB this_DT action_NN of_IN daboia_NN venom_NN on_IN blood_NN plasma_NN ,_, experiments_NNS were_VBD made_VBN to_TO ascertain_VB whether_IN or_CC not_RB this_DT poison_NN caused_VBD clotting_NN of_IN hydrocele_NN fluid_NN ,_, either_CC with_IN or_CC without_IN the_DT addition_NN of_IN a_DT soluble_JJ salt_NN of_IN lime_NN ._.
The_DT sample_NN of_IN hydrocele_NN fluid_NN used_VBN was_VBD clotted_VBN solidly_RB on_IN the_DT addition_NN of_IN a_DT small_JJ amount_NN of_IN oxalate_JJ plasma_NN ;_: it_PRP was_VBD ,_, in_IN fact_NN ,_, the_DT same_JJ sample_NN which_WDT was_VBD employed_VBN in_IN the_DT experiments_NNS with_IN cobra_NN venom_NN detailed_VBN in_IN Tables_NNP XIX_NNP and_CC XX_NNP of_IN the_DT protocols_NNS ._.
The_DT results_NNS of_IN both_DT these_DT series_NN of_IN experiments_NNS were_VBD ,_, however_RB ,_, entirely_RB negative_JJ (_( Table_JJ XXIV_NN of_IN protocols_NNS )_) ._.
Even_RB 5_CD milligrammes_NNS of_IN venom_NN produced_VBN no_DT clotting_NN in_IN 2_CD c.c_NN ._.
of_IN hydrocele_JJ fluid_NN either_CC alone_RB or_CC when_WRB lime_NN was_VBD added_VBN ._.
It_PRP is_VBZ evident_JJ ,_, then_RB ,_, that_IN in_IN whatever_WDT manner_NN daboia_VBZ venom_NN does_VBZ act_VB in_IN increasing_VBG coagulability_NN ,_, it_PRP can_MD not_RB replace_VB the_DT substances_NNS in_IN plasma_NN ,_, be_VB they_PRP nucleo-_JJ proteid_NN ,_, ferment_NN or_CC both_DT ,_, which_WDT are_VBP so_RB intimately_RB connected_VBN with_IN the_DT pheno-_JJ menon_NN of_IN coagulation_NN ._.
Further_RB ,_, Martin_NNP 's_POS hypothesis_NN ,_, namely_RB ,_, that_IN the_DT remarkable_JJ intravascular_NN clotting_VBG which_WDT some_DT snake_VBP venoms_NNS produce_VBP in_IN vivo_NN is_VBZ due_JJ to_TO the_DT setting_VBG free_JJ of_IN a_DT large_JJ quantity_NN of_IN nucleo-proteids_NNS ,_, the_DT result_NN of_IN the_DT great_JJ destruction_NN by_IN the_DT venom_NN of_IN cells_NNS and_CC of_IN red_JJ blood_NN corpuscles_NNS in_IN particular_JJ ,_, receives_VBZ no_DT support_NN from_IN the_DT observations_NNS with_IN daboia_NN poison_NN which_WDT I_PRP have_VBP collated_VBN above_IN ._.
When_WRB we_PRP consider_VBP that_IN this_DT venom_NN is_VBZ able_JJ to_TO increase_VB markedly_RB the_DT coagulability_NN of_IN citrate_NN or_CC oxalate_NN plasma_NN ,_, which_WDT no_DT doubt_NN contains_VBZ nucleo-proteids_NNS but_CC is_VBZ free_JJ from_IN cells_NNS ,_, it_PRP is_VBZ at_IN once_RB apparent_JJ that_IN this_DT 'destruction_NN '_POS theory_NN of_IN Martin_NNP does_VBZ not_RB furnish_VB a_DT sufficiently_RB definite_JJ mental_JJ picture_NN of_IN the_DT phenomena_NN ,_, when_WRB looked_VBD at_IN in_IN the_DT light_NN of_IN these_DT new_JJ facts_NNS which_WDT I_PRP have_VBP put_VBN forward_RB above_IN ._.
It_PRP would_MD appear_VB ,_, rather_RB ,_, that_IN the_DT ultimate_JJ cause_NN of_IN this_DT increase_NN of_IN coagulability_NN produced_VBN by_IN daboia_NN venom_NN is_VBZ some_DT obscure_JJ inter-action_NN between_IN the_DT poison_NN and_CC the_DT nucleo-proteids_NNS ,_, or_CC between_IN the_DT poison_NN and_CC the_DT clotting_NN ferment_NN ._.
It_PRP is_VBZ certainly_RB not_RB the_DT result_NN of_IN the_DT setting_VBG free_JJ of_IN normal_JJ nucleo-proteids_NNS through_IN the_DT destruction_NN of_IN the_DT cells_NNS by_IN the_DT poison_NN ._.
D_NNP 24_CD We_PRP have_VBP seen_VBN that_IN cobra_JJ venom_NN can_MD prevent_VB the_DT coagulation_NN of_IN citrate_NN plasma_NN ,_, which_WDT takes_VBZ place_NN on_IN the_DT addition_NN of_IN a_DT soluble_JJ salt_NN of_IN lime_NN ,_, and_CC that_IN ,_, on_IN the_DT other_JJ hand_NN ,_, daboia_NN venom_NN has_VBZ a_DT marked_VBN action_NN in_IN increasing_VBG the_DT coagula-_JJ bility_NN of_IN this_DT plasma_NN ._.
It_PRP is_VBZ interesting_JJ ,_, now_RB ,_, to_TO be_VB able_JJ to_TO record_VB a_DT series_NN of_IN experiments_NNS which_WDT were_VBD made_VBN with_IN the_DT object_NN of_IN determining_VBG what_WP would_MD be_VB the_DT result_NN of_IN the_DT addition_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS together_RB to_TO citrate_VB plasma_NN ._.
In_IN this_DT series_NN of_IN experiments_NNS 5_CD milligrammes_NNS of_IN cobra_NN venom_NNS were_VBD added_VBN to_TO each_DT tube_NN of_IN a_DT series_NN containing_VBG 2_CD c.c_NN ._.
of_IN plasma_NN ._.
This_DT ,_, as_IN we_PRP have_VBP seen_VBN ;_: is_VBZ a_DT quantity_NN of_IN venom_NN five_CD times_NNS greater_JJR than_IN the_DT amount_NN which_WDT can_MD completely_RB inhibit_VB the_DT coagulation_NN of_IN citrate_NN plasma_NN that_WDT takes_VBZ place_NN on_IN the_DT addition_NN of_IN a_DT soluble_JJ salt_NN of_IN lime_NN ._.
Half_PDT an_DT hour_NN afterwards_NNS a_DT different_JJ amount_NN of_IN daboia_NN venom_NN was_VBD run_VBN into_IN each_DT tube_NN ._.
This_DT amount_NN varied_VBD from_IN 5_CD to_TO 0.2_CD milligrammes_NNS ._.
When_WRB we_PRP compare_VBP the_DT results_NNS obtained_VBD in_IN this_DT series_NN of_IN experiments_NNS (_( Table_NNP XXV_NNP )_) with_IN the_DT results_NNS obtained_VBN in_IN the_DT series_NN of_IN experiments_NNS already_RB detailed_VBN (_( Table_JJ XXI_NN )_) in_IN which_WDT daboia_JJ venom_NN alone_RB was_VBD added_VBN to_TO the_DT plasma_NN ,_, it_PRP will_MD be_VB seen_VBN that_IN the_DT previous_JJ addition_NN of_IN this_DT large_JJ quantity_NN of_IN cobra_NN venom_NN had_VBD no_DT effect_NN in_IN even_RB delaying_VBG the_DT time_NN in_IN which_WDT the_DT various_JJ amounts_NNS of_IN venom_NN brought_VBN about_IN coagulation_NN of_IN the_DT plasma_NN ._.
In_IN other_JJ words_NNS ,_, the_DT presence_NN of_IN a_DT large_JJ quantity_NN of_IN cobra_NN venom_NN does_VBZ not_RB inhibit_VB in_IN the_DT slightest_JJS degree_NN the_DT clotting_VBG action_NN of_IN daboia_NN venom_NN ._.
Although_IN it_PRP is_VBZ hardly_RB justifiable_JJ to_TO make_VB deductions_NNS from_IN the_DT results_NNS of_IN experiments_NNS in_IN vitro_NN ,_, as_IN to_TO what_WP obtains_VBZ in_IN vivo_NN ,_, it_PRP appears_VBZ to_TO me_PRP interesting_JJ and_CC important_JJ to_TO draw_VB attention_NN to_TO the_DT following_JJ considerations_NNS ._.
I_PRP have_VBP mentioned_VBN in_IN an_DT early_JJ part_NN of_IN this_DT communication_NN that_IN ,_, when_WRB a_DT quantity_NN of_IN daboia_NN venom_NN not_RB sufficient_JJ to_TO cause_VB intravascular_JJ clotting_NN is_VBZ introduced_VBN directly_RB into_IN the_DT blood_NN stream_NN of_IN an_DT animal_NN ,_, the_DT blood_NN coagulability_NN becomes_VBZ markedly_RB diminished_VBN ._.
Further_RB ,_, along_IN with_IN Dr._NNP Hanna_NNP ,_, I_PRP have_VBP shown_VBN that_IN ,_, when_WRB this_DT negative_JJ phase_NN of_IN blood_NN coagulability_NN has_VBZ once_RB developed_VBN ,_, the_DT injection_NN of_IN even_RB large_JJ quantities_NNS of_IN daboia_JJ venom_NN does_VBZ not_RB increase_VB the_DT blood_NN coagula-_JJ bility_NN ,_, and_CC that_IN in_IN consequence_NN it_PRP is_VBZ now_RB impossible_JJ to_TO cause_VB death_NN from_IN intravas-_JJ cular_JJ thrombosis_NN ._.
Again_NNP ,_, I_PRP have_VBP shown_VBN in_IN this_DT paper_NN that_IN this_DT negative_JJ phase_NN of_IN blood_NN coagulability_NN is_VBZ not_RB obtained_VBN in_IN experiments_NNS with_IN daboia_JJ venom_NN and_CC citrate_NN blood_NN in_IN vitro_NN ._.
When_WRB we_PRP consider_VBP these_DT facts_NNS in_IN the_DT light_NN of_IN the_DT ex-_JJ periments_NNS ,_, both_DT in_IN vivo_NN and_CC in_IN vitro_NN ,_, with_IN cobra_JJ venom_NN ,_, the_DT results_NNS of_IN which_WDT have_VBP been_VBN collated_VBN above_IN ,_, namely_RB ,_, that_IN this_DT poison_NN has_VBZ both_DT in_IN vivo_NN and_CC in_IN vitro_NN a_DT marked_JJ power_NN of_IN preventing_VBG coagulation_NN or_CC diminishing_VBG the_DT coagulability_NN of_IN blood_NN ,_, and_CC in_IN the_DT light_NN of_IN the_DT experiments_NNS in_IN vitro_NN with_IN cobra_NN and_CC daboia_NN venoms_NNS together_RB ,_, great_JJ support_NN is_VBZ given_VBN to_TO the_DT conclusion_NN ,_, which_WDT I_PRP have_VBP already_RB stated_VBN ,_, namely_RB ,_, that_IN the_DT substances_NNS contained_VBN in_IN cobra_NN venom_NN which_WDT affect_VBP blood_NN coagulability_NN are_VBP quite_RB different_JJ ,_, both_DT in_IN nature_NN and_CC in_IN action_NN ,_, from_IN the_DT substances_NNS contained_VBN in_IN daboia_NN venom_NN which_WDT affect_VBP the_DT coagulability_NN of_IN the_DT blood_NN ._.
While_IN ,_, 25_CD therefore_NN ,_, superficial_JJ and_CC cursory_JJ observations_NNS might_MD lead_VB one_CD to_TO conclude_VB that_IN the_DT action_NN of_IN cobra_NN and_CC daboia_NN venoms_NNS on_IN blood_NN plasma_NN differed_VBD only_RB in_IN degree_NN and_CC not_RB in_IN nature_NN ,_, I_PRP hold_VBP that_IN these_DT observations_NNS are_VBP sufficient_JJ to_TO show_VB that_IN this_DT is_VBZ not_RB the_DT case_NN ,_, and_CC that_IN in_IN this_DT ,_, as_IN in_IN other_JJ respects_NNS ,_, these_DT two_CD snake_VBP venoms_NNS differ_VBP widely_RB from_IN one_CD another_DT ._.
Finally_RB ,_, I_PRP may_MD sum_VB up_RP the_DT conclusions_NNS ,_, which_WDT the_DT observations_NNS detailed_VBN in_IN this_DT paper_NN would_MD appear_VB to_TO justify_VB ,_, as_IN follows:26_NN foreshadowed_VBN in_IN a_DT paper_NN on_IN daboia_NN venom_NN which_WDT I_PRP published_VBD along_RB with_IN Dr._NNP Hanna.35_NNP (_( 6_CD )_) Martin_NNP 's_POS other_JJ hypothesis_NN ,_, namely_RB ,_, that_IN the_DT action_NN of_IN snake_NN venoms_NNS on_IN the_DT blood_NN coagulability_NN in_IN vivo_NN is_VBZ due_JJ to_TO the_DT setting_VBG free_JJ of_IN a_DT large_JJ quantity_NN of_IN nuclec-proteids_NNS ,_, the_DT result_NN of_IN the_DT destruction_NN of_IN cells_NNS ,_, and_CC especially_RB of_IN red_JJ blood_NN cells_NNS ,_, by_IN the_DT venom_NN ,_, is_VBZ not_RB a_DT theory_NN which_WDT forms_VBZ a_DT complete_JJ mental_JJ picture_NN of_IN the_DT phenomena_NN in_IN the_DT light_NN of_IN the_DT new_JJ facts_NNS I_PRP have_VBP put_VBN forward_RB ._.
It_PRP is_VBZ evident_JJ that_IN it_PRP will_MD have_VB to_TO be_VB considerably_RB modified_VBN to_TO suit_VB these_DT facts_NNS ._.
Protocols_NNS ._.
TABLE_NNP I.27_NNP TABLE_NNP II.28_NNP TABLE_NNP III.29_NNP TABLE_NNP V.30_NNP TABLE_NNP VII.31_NNP containing_VBG 1_CD c.c_NN ._.
of_IN citrate_NN blood_NN ._.
A_DT quantity_NN of_IN calcium_NN chloride_NN solution_NN ,_, namely_RB ,_, 0.5_CD c.c_NN ._.
of_IN a_DT 1_CD per_IN cent_NN ,_, solution_NN ,_, was_VBD added_VBN to_TO each_DT tube_NN at_IN varying_VBG intervals_NNS after_IN the_DT venom_NN ._.
This_DT amount_NN clotted_VBD the_DT control_NN in_IN 2_CD minutes_NNS ._.
Citrate_NNP blood_NN (_( 1_CD in_IN 50_CD )_) ._.
Cobra_NNP venom_NN ,_, 1_CD milli-_JJ gramme_NN ,_, added_VBD at_IN Calcium_NNP chloride_VBP solution_NN 1_CD (_( 1_CD per_IN cent_NN ._. )_)
(_( 0.5_CD c.c_NN ._.
added_VBN at_IN Result_NNP ._.
1_CD c.c_NN ._.
2.23_CD p.m._NN 2.23_CD p.m_NN ._.
Solid_JJ clot_NN in_IN 2_CD hours_NNS ._.
1_CD c.c_NN ._.
2.43_CD p.m._NN 2.58_CD p.m_NN ._.
Slight_NNP clot_NN in_IN 2_CD hours_NNS ._.
1_CD c.c_NN ._.
2.17_CD p.m._NN 2.47_CD p.m_NN ._.
Liquid_NNP after_IN 2¬Ω_CD hours_NNS ._.
1_CD c.c_NN ._.
2.17_CD p.m._NN 3.17_CD p.m._NN Ditto_NNP ._.
1_CD c.c_NN ._.
(_( control_NN )_) Nil_NNP ._.
3_CD p.m_NN ._.
Solid_JJ clot_NN in_IN 2_CD minutes_NNS ._.
TABLE_NNP IX.32_NNP TABLE_NNP X.33_NNP TABLE_NNP XI.34_NNP TABLE_NNP XII.35_NNP Varying_NNP amounts_NNS of_IN a_DT 0.2_CD per_IN cent_NN ._.
solution_NN of_IN daboia_NN venom_NNS were_VBD added_VBN to_TO each_DT tube_NN ._.
No_DT lime_JJ solution_NN was_VBD added_VBN ._.
Citrate_NNP blood_NN (_( 1_CD in_IN 50_CD )_) ._.
Daboia_NNP venom_NN in_IN milligrammes_NNS ._.
Result_NN ._.
1_CD c.c_NN ._.
2_CD Solid_JJ clot_NN in_IN 37_CD minutes_NNS ._.
1_CD c.c_NN ._.
1.6_CD Solid_JJ clot_NN in_IN 39_CD minutes_NNS ._.
1.c.c_CD ._.
1.4_CD Solid_JJ clot_NN in_IN 41_CD minutes_NNS ._.
1_CD c.c_NN ._.
1.2_CD Solid_JJ clot_NN in_IN 43_CD minutes_NNS ._.
1_CD c.c_NN ._.
1_CD Solid_JJ clot_NN in_IN 1_CD hour_NN and_CC 12_CD minutes_NNS ._.
1_CD c.c_NN ._.
0.8_CD Clotted_VBN but_CC not_RB solid_JJ in_IN 1_CD hour_NN ._.
1_CD c.c_NN ._.
0.6_CD Solid_JJ clot_NN in_IN 1¬æ_CD hours_NNS ._.
1_CD c.c_NN ._.
0.3_CD Clotted_VBN but_CC not_RB solid_JJ in_IN 2_CD hours_NNS ._.
1_CD c.c_NN ._.
0.2_CD Ditto_NNP ._.
TABLE_NNP XIV.36_NNP TABLE_NNP XV.37_NNP TABLE_NNP XVII38_VBZ The_DT following_NN was_VBD the_DT result_NN obtained:39_NN TABLE_NNP XX.40_VBZ The_DT following_NN was_VBD the_DT result_NN obtained:41_MD daboia_VB venom_NN ._.
The_DT strengths_NNS of_IN the_DT venom_NN were_VBD 1_CD per_IN cent_NN ._.
and_CC 0.2_CD per_IN cent_NN ._.
dissolved_VBN in_IN normal_JJ saline_JJ solution_NN ._.
The_DT following_JJ results_NNS were_VBD obtained:42_JJ TABLE_NNP XXIV_NN ._.
43_CD TABLE_NNP XXV.44_NNP (_( 3_CD )_) Allbutt_NNP 's_POS ``_`` System_NNP of_IN Medicine_NNP ,_, ''_'' Voulme_NNP II_NNP ,_, page_NN 809_CD ._.
(_( 4_CD )_) 'Journal_CD of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1902_CD ,_, Volume_NN VIII_NNP ,_, page_NN 1_CD ._.
(_( 5_CD )_) Wall_NNP :_: ``_`` Indian_JJ Snake_NNP poisons_NNS ,_, their_PRP$ nature_NN and_CC effect_NN :_: ''_'' W._NNP H._NNP Allen_NNP &_CC Co._NNP ,_, London_NNP ,_, 1883_CD ._.
(_( 6_CD )_) 'Lancet_CD ,_, '_'' January_NNP 5th_CD ,_, 1901_CD ,_, page_NN 25_CD ._.
(_( 7_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 8_CD )_) 'Scientific_CD Memoirs_NNP by_IN Medical_NNP Officers_NNP of_IN the_DT Army_NNP in_IN India_NNP :_: '_POS Part_NNP IX_NNP ,_, 1895_CD ,_, page_NN 1_CD ,_, and_CC Part_NNP XI_NNP ,_, 1898_CD ,_, page_NN 1_CD ._.
(_( 9_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 10_CD )_) 'Scientific_CD Memoirs_NNP by_IN Medical_NNP Officers_NNP of_IN the_DT Army_NNP in_IN India_NNP :_: '_POS Part_NNP XI_NNP ,_, 1898_CD ,_, page_NN 31_CD ._.
(_( 11_CD )_) 'Journal_CD of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1900_CD ,_, Volume_NN VI_NNP ,_, page_NN 273_CD ._.
(_( 12_CD )_) 'Journal_CD of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1900_CD ,_, Volume_NN VI_NNP ,_, page_NN 415_CD ._.
(_( 13_CD )_) The_DT term_NN 'isotonic_NNP '_'' is_VBZ not_RB used_VBN in_IN the_DT strictly_RB physiological_JJ sense_NN ._.
I_PRP have_VBP employed_VBN it_PRP to_TO mean_VB the_DT weakest_JJS strength_NN of_IN salt_NN solution_NN in_IN which_WDT no_DT 'laking_VBG '_'' of_IN the_DT blood_NN was_VBD observed_VBN :_: in_IN other_JJ words_NNS ,_, 'laking_VBG '_'' and_CC not_RB swelling_VBG of_IN the_DT corpuscles_NNS was_VBD taken_VBN as_IN a_DT standard_NN ._.
(_( 14_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 15_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 16_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 17_CD )_) 'Journal_CD of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1900_CD ,_, Volume_NN VI_NNP ,_, page_NN 273_CD ._.
(_( 18_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 19_CD )_) Quoted_VBN from_IN a_DT paper_NN by_IN Professor_NNP Martin_NNP :_: 'On_CD some_DT effects_NNS upon_IN the_DT blood_NN produced_VBN by_IN the_DT injection_NN of_IN the_DT venom_NN of_IN the_DT Australian_JJ Black_NNP Snake_NNP (_( Pseudechis_NNP porphyriacus_NN )_) '_POS :_: 'Journal_CD of_IN Physiology_NNP ,_, '_'' Volume_NN XV_NNP ,_, No_NNP ._.
4_CD ,_, 1893_CD ._.
(_( 20_CD )_) 'Proceedings_NNS of_IN Royal_NNP Society_NNP of_IN N._NNP S._NNP Wales_NNP :_: '_POS July_NNP 3rd_CD ,_, 1895_CD ._.
Clifford_NNP Allbutt_NNP 's_POS 'System_NN of_IN Medicine_NNP ,_, '_'' Volume_NN II_NNP ,_, page_NN 809_CD ._.
(_( 21_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 22_CD )_) 'Journal_CD of_IN Physiology_NNP ,_, '_'' Volume_NN XV_NNP ,_, No_NNP ._.
4_CD ,_, 1893_CD ._.
(_( 23_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 24_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 25_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 26_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 27_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 28_CD )_) 'Journal_CD of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1902_CD ,_, Volume_NN VIII_NNP ,_, page_NN 1_CD ._.
(_( 29_CD )_) 'Journal_CD of_IN Physiology_NNP ,_, '_'' Volume_NN XV_NNP ,_, No_NNP ._.
4_CD ,_, 1893_CD ._.
(_( 30_CD )_) Quoted_VBN by_IN Martin_NNP in_IN above_JJ paper_NN ._.
(_( 31_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 32_CD )_) Loc_NNP ._.
Cit_NNP ._.
45_CD (_( 33_CD )_) Many_JJ experiments_NNS were_VBD made_VBN to_TO ascertain_VB the_DT minimum_JJ amount_NN of_IN citrate_NN of_IN soda_NN which_WDT could_MD be_VB relied_VBN on_IN to_TO keep_VB rabbit_NN 's_POS blood_NN permanently_RB liquid_VBZ ._.
It_PRP was_VBD found_VBN that_IN when_WRB the_DT citrate_NN was_VBD present_JJ in_IN the_DT proportion_NN of_IN 1_CD in_IN 150_CD ,_, clotting_VBG sometimes_RB occurred_VBN and_CC sometimes_RB did_VBD not_RB ,_, and_CC when_WRB in_IN the_DT proportion_NN of_IN 1_CD in_IN 100_CD ,_, the_DT blood_NN always_RB remained_VBD fluid_NN for_IN an_DT indefinite_JJ time_NN ._.
(_( 34_CD )_) Loc_NNP ._.
Cit_NNP ._.
(_( 35_CD )_) Journal_NNP of_IN Pathology_NNP and_CC Bacteriology_NNP :_: '_POS Edinburgh_NNP and_CC London_NNP ,_, 1902_CD ,_, Volume_NN VIII_NNP ,_, page_NN 1_CD ._.
No_DT ._.
4_CD ._.
(_( NEW_JJ SERIES_NNP ._. )_)
SCIENTIFIC_NNP MEMOIRS_NNP ._.
BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ._.
ON_IN THE_DT ACTION_NNP OF_IN THE_NNP VENOMS_NNP OF_IN THE_NNP COBRA_NNP (_( NAJA_NNP TRIPUDIANS_NNP )_) AND_NNP OF_IN THE_NNP DABOIA_NNP (_( DABOIA_NNP RUSSELLII_NNP )_) ON_IN THE_NNP RED_NNP BLOOD_NNP CORPUSCLES_NNP AND_NNP ON_NNP THE_NNP BLOOD_NNP PLASMA_NNP ._.
BY_NNP GEORGE_NNP LAMB_NNP ,_, M.D._NNP ,_, CAPTAIN_NNP ,_, I.M.S_NNP ._.
ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP .GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75024043.tif_CD ]_JJ CALCUTTA_NNP :_: OFFICE_NN OF_IN THE_NNP SUPERINTENDENT_NNP OF_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP ._.
1903_CD ._.
Price_NN As_IN ._.
8_CD or_CC 9d_CD ._.
